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Background. Cognitive Behavioural Analysis System of Psychotherapy 
(CBASP) has been developed to treat individuals affected by persistent 
depressive disorder (PDD). There is a growing number of empirical studies to 
suggest that CBASP is effective in treating chronically depressed population. 
Taking into account these findings as well as the chronic and debilitating 
nature of persistent depression, it can be invaluable, when planning 
treatment, to understand the factors contributing to and maintaining this 
condition, as well as mechanisms of change involved in CBASP. 
Purpose. A systematic review aimed to establish the quality of evidence 
indicating the effectiveness of CBASP when addressing difficulties with 
interpersonal functioning which are believed to be causing and maintaining 
depressive symptoms according to the theory of persistent depression 
developed by McCullough (2000). McCullough hypothesised that childhood 
trauma leads to an impairment in the cognitive-emotional development, which 
then leads to interpersonal difficulties that result in depressive symptoms. An 
empirical study aimed to identify the strength of the relationships between 
different constructs in the theoretical foundations of CBASP.  
Methods. A systematic literature search was conducted identifying research 
reporting the effects of CBASP intervention on interpersonal functioning in the 
clinical samples affected by PDD or depression of chronic nature but not 
meeting all the criteria for PDD. The search yielded nine papers which met 
inclusion and exclusion criteria. The Effective Public Health Practice Project 
quality assessment tool was employed to assess the quality of the included 
studies. In order to collect data for empirical study, a cross-sectional design 
was used. Clinicians working in the mental health teams in the local board 
were asked to identify adult patients on their caseloads who were affected by 
PDD. The clinicians were then invited to introduce the study to these patients 
and, if the patient showed an interest, offer them a questionnaire pack to read 
at home. Thirty-two patients with PDD completed and returned a set of 
questionnaires measuring childhood trauma, pre-operational 
functioning/reflective functioning, interpersonal difficulties, and depressive 
symptoms. A series of multiple regression analyses were used to analyse the 
results. 
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Results. The systematic review provided evidence supporting the hypothesis 
that CBASP intervention leads to an improvement in the area of interpersonal 
functioning. The majority of the assessed studies demonstrated the 
improvements on the measures of interpersonal functioning, while all of the 
studies showed reductions in depressive symptoms. The methodological 
quality of the studies has been evaluated to be of good or very good standard 
which strengthened the reliability and validity of the results. Findings from the 
empirical study, somewhat surprisingly, failed to demonstrate the 
hypothesised association between childhood trauma, pre-operational thinking, 
interpersonal difficulties and the severity of depression. Childhood adversity, 
pre-operational thinking and interpersonal difficulties did not predict the 
severity of depressive symptoms. The relationship between childhood trauma 
and interpersonal functioning, as well as interpersonal functioning and 
depression, did not reach statistical significance, even when the subscale of 
the Inventory of Interpersonal Problems (Horowitz, Alden, Wiggins, & Pincus, 
2000) measuring a hostile submissive interpersonal style associated with 
persistent depression, was entered into the model. 
Discussion. The findings from the first chapter of this thesis provide evidence 
suggesting that CBASP intervention leads to an improvement in the area of 
interpersonal functioning and reduction in depressive symptomatology. 
Importantly, the review's results demonstrated that while the assessed studies 
were primarily of good quality, more studies investigating specific 
mechanisms of change involved in the CBASP intervention are needed. The 
analyses which were part of the empirical study revealed the lack of 
associations between the constructs used by McCullough in his theory of 
persistent depression. While it is possible that the relationships between the 
discussed constructs are weaker than previously established, there have 
been a number of methodological limitations, such as a potentially 
unrepresentative sample and its small size, which might have contributed to 






2. Lay summary of thesis 
Introduction. Depression is a mental health condition that is often disabling 
and challenging for people who are affected by it. In about one third of cases, 
depression has a chronic nature meaning it persists over a number of years. 
Cognitive Behavioural Analysis System of Psychotherapy (CBASP) is a 
therapy that has been developed to treat chronic depression. CBASP was 
developed based on a theory that describes chronic depression as happening 
when, as a result of early negative experiences, an individual has difficulties 
with interpersonal interactions. 
Aims and methods. The first part of this thesis aimed to determine whether 
there is evidence in the current research literature supporting the idea that 
CBASP leads to less difficulties in interpersonal interactions. It also sought to 
establish whether the research studies in the area are of good methodological 
quality. A second study aimed to explore the nature of relationships between 
childhood trauma, cognitive-emotional development, interpersonal functioning, 
and chronic depression. 
Main findings. The findings in this thesis suggest that CBASP intervention is 
helpful to individuals affected by chronic depression, in that, it leads to less 
interpersonal difficulties, and helps to reduce depressive symptoms. The first 
study found that the evidence which showed these improvements is based on 
studies which have been rated, on the whole, as being of good quality. The 
second study found no evidence for relationships between childhood trauma, 
cognitive-emotional development, interpersonal difficulties, and depressive 
symptoms suggesting that these relationships might be weaker than 
previously thought. 
Conclusions. The findings from this thesis suggest that CBASP leads to an 
improvement in interpersonal difficulties and depressive symptoms. Future 
research can focus on identifying specific aspects of interpersonal functioning 
that improve following this intervention to help therapists better understand 
the nature of difficulties addressed by CBASP. Importantly, no supporting 
evidence was found for relationships between the different factors which are 
believed to cause and maintain chronic depression. Given the lack of 
research in this area, in order to be able to draw strong conclusions, more 
studies investigating the theoretical model CBASP is based on are necessary. 
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3. Chapter 1: Systematic review 
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Background. Cognitive Behaviour Analysis System of Psychotherapy 
(CBASP) has been specifically designed to treat patients affected by 
Persistent Depressive Disorder (PDD). CBASP addresses the interpersonal 
functioning of the individual through a number of therapeutic techniques. This 
review sought to determine whether CBASP improves interpersonal 
functioning in chronically depressed patients. 
Methods. A systematic literature search was conducted for research 
measuring the effects of CBASP on interpersonal functioning in the individuals 
affected by PDD or depression of chronic nature but not meeting all the 
criteria for PDD. The Effective Public Health Practice Project quality 
assessment tool was used to evaluate the quality of the included papers.  
Results. Nine papers met the inclusion and exclusion criteria. Six out of nine 
studies have revealed the improvements on the measures of interpersonal 
functioning, while all of the studies demonstrated improvements in depressive 
symptomatology following the CBASP intervention. The methodology of the 
studies under investigation has been found to be of a good standard, with the 
majority of the papers being assigned strong or moderate ratings which is 
indicative of the reliability and validity of the results. 
Limitations. The review yielded a relatively small number of papers due to 
the limited research into the area, which might have affected the 
generalisability of the findings. There was also a lack of consistency among 
the studies regarding the definition of interpersonal functioning and measures 
used to assess it. Future avenues for research in this area include identifying 
specific aspects of interpersonal functioning which are associated with a 
reduction in chronic symptoms in order to help practitioners tailor 
psychological interventions for this population. 









3.2.1. Persistent depression 
The prevalence of depressive disorders in Western countries is estimated at 
17-19% (Jacobi et al., 2004; Kessler et al., 2005) and in about 20-35% cases 
the nature of depression is persistent (Arnow & Constantino, 2003; Dunner, 
2001; Gilmer et al., 2005; Klein & Santiago, 2003). The average duration of 
persistent depression (PD) is approximately 20 years (Gilmer et al., 2005; 
Kocsis, 2003). With its relatively high prevalence, depression can be one of 
the major factors affecting an individual's quality of life and a country's 
economy (Greenberg et al., 2003; Murray et al., 2012). 
 The fifth and latest edition of The Diagnostic and Statistical Manual of 
Mental Disorders (DSM-V) (American Psychiatric Association, 2013) has 
slightly amended the diagnoses and definitions of depressive disorders using 
the duration of an episode as one of the main criterion. In order to meet 
criteria for a major depressive disorder (MDD), five or more symptoms from 
the suggested list (with at least one of them being depressed mood or loss of 
interest or pleasure) have to be present during the same two week period, 
and represent a change from previous functioning (see Appendix B). DSM-V 
also merged presentations of chronic depression and dysthymia 
(characterised in DSM-IV by milder depressive symptoms lasting for at least 
two years (American Psychiatric Association ,1994) into one persistent 
depressive disorder (PDD). PDD is diagnosed if depressed mood continues to 
last for most of the day, more days than not, for at least two years, and is 
accompanied by two other symptoms from the suggested list (see Appendix 
C).  
 Although several types of PD can be identified in the literature i.e. 
dysthymia, chronic major depression, recurrent major depression with 
incomplete remission during episodes and double depression (Dunner, 
Lipschitz, Pitts, & Davies, 2005; Kocsis, 2000), there are no established 
differences in their aetiology. PD, which is often referred to as 'chronic 
depression' in research literature, can be seen as an umbrella term with its 
subcategories showing more similarities than differences (Dunner et al. 2005; 
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Klein & Santiago, 2003). For the purpose of this review, chronic presentations 
of depression will be referred to as PDD as per DSM-V terminology. 
  PDD has been shown to lead to a significantly higher global burden of 
disease and associated costs than episodic depression (Arnow & Constantino, 
2003; Greenberg et al., 2003). For example, chronic forms of depression are 
associated with higher use of health care (Gilmer et al., 2005; Klein, 
Schwartz, Rose, & Leader, 2000; McFarland & Klein, 2005). In the study by 
Klein et al. (2000), patients with a diagnosis of dysthymic disorder were eight 
times more likely to be admitted to a psychiatric unit than patients with 
episodic major depressive disorder. In many cases, PDD persists despite 
pharmacological or therapeutic intervention (Ghaemi, 2008; Kocsis, 2003). 
Interestingly, about 70% individuals with PDD report onset before the age of 
21 years old (Cassano, Akiskal, Perugi, Musetti, & Savino, 1992; Keller et al., 
2000). In fact, depression with a chronic course has been often shown to be 
associated with early childhood adversity such as neglect as well as physical 
or sexual abuse (Chapman et al., 2004, Korkeila et al., 2005; Lizardi et al., 
1995; Wiersma et al., 2009). Chronically depressed patients also report more 
difficulties with psychosocial functioning (Arnow & Constantino, 2003; Berndt 
et al., 2000), and, in particular, interpersonal skills (Hammen & Brennan, 
2002; Miller et al., 1998; Petty, Sachs-Ericsson, & Joiner, 2004). While the 
impact of depression on mental health has been well documented, the 
mechanisms leading to and perpetuating depressive symptoms are less 
understood. Therefore, this review will focus on research studies investigating 
the effects of CBASP on interpersonal functioning. It will specifically explore 
the quality of existing literature in order to be able to draw well-grounded 
conclusions. 
   
3.2.2. Interpersonal functioning and chronic depression 
 Interpersonal difficulties can include a broad range of problems related 
to social interaction and engagement within both intimate relationships or 
broader interpersonal situations (Hartmann, Zeeck, & Barrett, 2010). There is 
a strong evidence base emphasising the key role of interpersonal functioning 
in mental health. Being able to form and maintain secure and fulfilling 
interpersonal relationships has been argued to be essential to an individual's 
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happiness and overall wellbeing (e.g. Berscheid & Peplau, 1983). In contrast, 
difficulties within the area of interpersonal functioning have been linked to a 
range of psychological problems such as depression (e.g. Barrett & Barber, 
2007), anxiety (e.g. McEvoy, Burgess, Page, Nathan, & Fursland, 2013), 
eating disorders (e.g. Arcelus, Haslam, Farrow, & Meyer, 2013), and 
personality disorders (e.g. Pincus & Wiggins, 1990). Furthermore, difficulties 
within interpersonal functioning have been suggested to be one of the major 
factors causing and maintaining depressive episodes. Insecure attachment 
patterns, submissiveness, lack of assertiveness, social disinhibition, and poor 
interpersonal skills have been found to predict both the onset and the 
maintenance of depression (Barrett & Barber, 2007; Constantino et al., 2008; 
Coyne, 1976; Eberhart & Hammen, 2006; Joiner & Timmons, 2002; Ravitz, 
Maunder, & McBride, 2007; Scharfe, 2007). 
 There is strong empirical evidence indicating that an individual's 
interpersonal style is linked to the early learning experiences which include 
patterns of attachment to caregivers (Horowitz, Rosenberg, & Bartholomew, 
1993). According to interpersonal theory (Leary, 1957; Sullivan, 1953), people 
tend to engage in behaviours which help them to maintain a psychological 
connection with an earlier attachment figure, even if these, are maladaptive. 
Individuals are expected to enact interpersonal styles that are close in a 
representational or literal way to that of their childhood attachment 
relationships. Despite the likely distress associated with the maladaptive way 
of relating to others and potential difficulties within social relationships 
associated with this, it has been suggested that keeping the interpersonal 
patterns unchallenged avoids a potential increase in anxiety, which can be 
triggered by relating to others in a different way to the usual, and serves to 
protect the current self-image.  
 Interpersonal theories of depression argue that interpersonal factors 
and mechanisms often maintain depressive symptoms (Coyne, 1976; 
Lewinsohn, 1974). For example, a person who can be described as having an 
anxious or ambivalent attachment pattern and abandonment schema can 
introduce a number of challenges into the relationship by engaging in 
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behaviours that can be difficult for the other party such as excessive 
reassurance seeking, proximity seeking, and looking for approval (Mikulincer 
& Shaver, 2005). Similarly, a person who can be identified as having an 
avoidant or dismissive attachment pattern and who is often in charge in 
relationships, might avoid emotional intimacy, acknowledging her/his 
emotional states, and primarily rely on self (Shallcross, Howland, Bemis, 
Simpson & Frazier, 2011; Shaver & Mikulincer, 2007). According to Coyne's 
interactional theory of depression (1976), a person exhibiting depressive 
symptoms tends to be initially supported by their social network. However, 
with time, excessive reassurance seeking and ongoing symptoms can lead to 
a negative affect in others which contributes to a vicious cycle of depressive 
symptoms. In fact, factors such as excessive reassurance seeking, social 
isolation, negative emotions, and rejection by other people have been linked 
to depression (Joiner & Metalsky, 2001; Starr & Davila, 2008). 
  Interpersonal behaviour has been conceptualised using two 
dimensions which have been supported by empirical findings. The first, 
dimension of affection, is captured on an axis representing a continuum of 
hostile to friendly behaviour, and the second, the dimension of power, is 
captured on an axis representing a continuum of submissive to dominant 
behaviour (Millar, Rogers-Millar, & Villard,1978). Importantly, two individuals 
have a reciprocal impact on each other's behaviour as they interact. In fact, 
one person's way of acting can invite a particular type of behaviours from the 
other person. These ways of engaging often compliment each other, i.e. two 
individuals behaving in a way that can be described as falling at opposing 
ends of a particular dimension. For example, when person A takes a dominant 
position in an interaction, person B stays submissive. It is believed that 
conflict in relationships is more likely when the behaviours of two people fall 
on the same dimension of an axis e.g. when two people are behaving in a 
dominant way. The research into interpersonal correlates of PDD is scarce. 
However, a recent review by Bird, Tarsia and Schwannauer (2018) found a 
tendency for individuals with PDD to exhibit higher levels of hostile-
submissive interpersonal style as opposed to with those with MDD. 
Importantly, due to a relatively small number of included publications (12) in 
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the review, secondary analyses using baseline samples of intervention trials 
with normative data as controls, as well as relatively low overall quality of the 
studies assessed, more research is required to be able to draw well supported 
conclusions. 
3.2.3. Cognitive-Behavioural Analysis System of Psychotherapy for PD
 Cognitive Behavioural Analysis System of Psychotherapy (CBASP) is a 
psychological intervention designed specifically to treat people who have 
been suffering from early-onset PDD and who have difficulties with their 
interpersonal functioning (McCullough, 2003). According to the theoretical 
model CBASP is based on, PDD, which has an onset before an individual is 
21 years of age, is caused by an impairment in cognitive-emotional 
development and interpersonal functioning caused by experiences of 
childhood adversity. McCullough explained this impairment in the 
interpersonal domain using a concept of 'preoperational thinking' studied by 
Piaget (1981). Piaget noticed that children aged 5-7 function cognitively and 
emotionally at a preoperational level, which can be further described as 
egocentric and prelogical. He also observed that when a typically developing 
child reaches the age of about 7 years old, she/he develops skills that allow 
for more logical and less egocentrical thinking. McCullough (2003) suggested 
that children who are traumatised spend all their energy on trying to survive, 
which limits their opportunities to learn about different ways of experiencing 
the world, and as a result, affects their interpersonal effectiveness. Such 
children have been hypothesised to function psychologically at the 
preoperational level and not be able to understand events from other person's 
perspective. According to McCullough, functioning at the preoperational level 
in the interpersonal domain is a risk factor for developing PDD. Importantly, 
McCullough also suggested that late-onset depression is likely to be caused 
by an individual's relapse into the preoperational stage, which may be 
triggered by experiences of particularly stressful events despite a typical 
childhood.  
 CBASP was developed in order to address the long-standing 
maladaptive cognitive-behavioural patterns and interpersonal difficulties found 
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in the individuals affected by PDD (McCullough, 2000; McCullough 2006). 
According to McCullough (a view supported by the results of the 
aforementioned research by Bird et al., 2018), individuals affected by PDD 
exhibit a hostile-submissive, or socially avoidant, interpersonal style which 
limits their opportunities for meaningful and rewarding interpersonal 
experiences. McCullough further argues that PDD is maintained by fears of 
interpersonal encounters and associated avoidant behaviours which have 
their origin in past relationship experiences (2006) and result in 
"disconnection" between a person and his/her environment. Therefore, 
CBASP was developed to facilitate changes in the patients' interpersonal 
behaviours, cognitions and affective states which, in turn, are believed to 
result in a higher awareness of the functionality of their behaviour, increased 
opportunities to connect to their environment, and an enhanced sense of 
control. Specific therapeutic techniques involved in CBASP have been 
developed to help the person move from a socially avoidant/hostile-
submissive interpersonal style to a more assertive and friendly one.  
 While the impact of depression on mental health has been revealed 
and discussed in extensive research, the mechanisms which lead to, and 
often perpetuate depressive symptomatology are not very well understood. 
Gaining a deeper understanding of these mechanisms would allow the 
therapists to identify the specific areas to target in therapy. Previous research 
indicated that changes within interpersonal functioning, such as changes 
within patients' interpersonal styles (as perceived by significant others who did 
not take part in treatment or by therapists), are related to better outcomes 
(Constantino et al., 2012; Grosse Holtforth, Altenstein, Ansell, Schneider, & 
Caspar, 2012). Importantly, even though therapy outcomes usually focus 
more on reduction in depressive symptoms rather than improvements in 
social functioning, from a patient's perspective the latter might be more 
significant. Previous studies found that positive changes within social 
functioning were seen by patients as one of the three most important factors 
when considering whether their depression was in remission (Zimmerman et 
al., 2006), and were seen as a significant treatment goal (Battle et al., 2010). 
The majority of CBASP sessions involve a situational analysis technique 
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which helps the patient to address the maladaptive cognitive, behavioural, 
emotional, and interpersonal responses believed to maintain the depressive 
symptoms. Completing a situational analysis requires the patient to engage in 
formal operational thinking in the interpersonal context. It is hoped that 
through this exercise, patients realise the effect they have on others and their 
environment, and that their interpersonal style might be a perpetuating factor 
maintaining their depressive symptoms. 
 A systematic review has been published discussing evidence from a 
relatively small number of randomised clinical trials investigating the efficacy 
of CBASP in PDD (Negt et al., 2016). The authors have reviewed 6 studies 
involving 1510 patients and studied the effects of CBASP on depressive 
symptoms. The combined overall effect sizes of CBASP versus other 
treatments or treatment as usual revealed a significant albeit small effect. 
Interestingly, moderate-to-high effect sizes were found when CBASP was 
compared to interpersonal psychotherapy or treatment as usual. CBASP 
enhanced by antidepressant medication showed better results than the 
medication itself, which showed similar benefits to CBASP alone. The overall 
effect sizes observed in the Negt et al.’s review were smaller than those 
reported by meta-analyses investigating alternative depression treatments. 
Medium overall effect sizes were found in studies exploring the benefits of 
CBT (d=0.67, Cuijpers et al., 2010a), IPT (d=0.63; Cuijpers et al., 2011) and 
short-term psychodynamic therapy (d=0.69; Driessen et al., 2010) on 
depression.  
It seems important to bear in mind that the individuals who participated 
in the trials reviewed by Negt et al. were affected by chronic, and often 
treatment resistant, depression rather than by a combination of persistent and 
episodic depression present in the other reviews. This seems crucial when 
reflecting on the evidence supporting the effectiveness of CBASP. The Matrix 
(2015) as well as the most recent NICE guidelines (National Institute for 
Clinical Excellence, 2017) listed CBASP as the first line of treatment for PDD. 
NICE guidelines specifically recommended CBASP or CBT in combination 
with antidepressant medication. While the Matrix graded the quality of 
evidence supporting the effectiveness of CBASP as ‘B’ (which requires the 
evidence to include either well-conducted non randomized clinical studies or 
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RCT of lower quality demonstrating overall consistency of results), the NICE 
guidelines assessed several CBASP RCT’s as being of ‘very low to moderate 
quality’ (the NICE grading system explores, among other things, sample size 
and risk of bias). It seems that despite the inconsistent quality of evidence and 
the limited number of studies published in the area, the reviewers are seeing 
CBASP as a promising treatment in the area of persistent depression due to 
evidence suggesting small but considerable effect sizes and clinically 
significant changes in the difficult to treat population.  
 It is worth noting that despite a different focus of the present 
systematic review to Negt et al.’s paper, there is a degree of overlap 
regarding the literature discussed. Four out of six papers included in the 
systematic review by Negt and colleagues have also been analysed here. 
Importantly, the main interest of this systematic review were the changes in 
interpersonal functioning following CBASP therapy, which despite being a 
crucial factor in patients’ wellbeing, were not covered by Negt et al.’s review.  
As follows, two papers included in Negt et al. review which did not use a 
measure of interpersonal functioning as part of their design (Kocsis, 
Gelenberg, Rothbaum, Klein, Trivedi, Manber et al., 2009;  Wiersma, Van 
Schaik, Hoogendorn, Dekker, Van, Schoevers et al., 2014) were excluded 
from this review. 
 Taking into account the high prevalence of PDD, its chronic nature and 
resistance to treatment, as well as its negative impact on psychosocial 
functioning, it is extremely important to continue research which supports 
practitioners in establishing the most effective ways of working with patients 
affected by this condition. While Negt et al. review found evidence to support 
the efficacy of CBASP, it is worth bearing in mind that the number of the 
reviewed studies was relatively small, the studies relied on similar 
methodology affecting the richness of the data, and there was limited data 
assessing the long-term effects of CBASP. Therefore, it is important to keep 
reviewing the most up-to-date evidence as further research is being carried 
out. 
  
3.2.4. Previous reviews 
 A number of published review studies informed the current review.  
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Renner, Cuijpers and Huibers (2014) conducted a meta-analysis evaluating 
studies of psychotherapy for depression that included measures of social 
functioning. All of the 31 included studies involved a control condition. The 
findings revealed the impact of psychotherapy on the social functioning of 
small to moderate effect size with higher quality studies producing lower effect 
sizes. The changes within the social domain were associated with, but not 
fully explained by, improvements in depressive symptoms. Importantly, the 
review investigated the effects of all types of psychotherapy and was not 
limited to CBASP. 
 The aforementioned review by Bird et al. (2018) analysed the research 
measuring the relationship between depression and hostility and/or 
submissiveness. A meta-analysis was conducted to establish the strength of 
that relationship. The results have supported McCullough's hypothesis which 
posits that individuals reporting PDD exhibit a hostile-submissive, or socially 
avoidant, interpersonal style. The review also established that the individuals 
with PDD tend to be more hostile-submissive in their interpersonal style as 
compared to those with episodic depression. Importantly, the review 
highlighted the limited research in this area and a lack of direct comparison 
between individuals affected by PDD and episodic depression. 
 
3.2.5. Aim of the current review 
 This review aimed to evaluate the quality of studies investigating the 
impact of CBASP on interpersonal functioning in order to assess the validity 
and reliability of existing empirical evidence in this area. Importantly, both 
theory and empirical research have acknowledged that adaptive interpersonal 
functioning is important for many reasons. Firstly, according to the theoretical 
model described above, challenges in interpersonal functioning can lead to 
PDD. If this model is correct, resolving difficulties within the social domain of 
someone's life is likely to lead to a reduction in their depressive symptoms. 
Treating PDD has been a challenging task and psychological interventions 
used with this patient group have shown limited benefits. CBASP has been 
the only therapy developed to specifically treat PDD through addressing 
interpersonal functioning of the individual. Such a review could help validate 
the theory behind this particular therapy and justify its implementation with 
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patients. A better understanding of the benefits of CBASP is likely to impact 
the treatment delivery, prevention strategies, and wider social policy. Finally, 
assessing the dropout rates among patients attending CBASP intervention will 
allow us to draw some conclusions about its feasibility. 
 
3.2.6. Research questions 
 1) Does CBASP intervention improve interpersonal functioning in 
individuals affected by PD? 
 2) Does CBASP intervention reduce depressive symptoms in 
individuals affected by PD? 
 3) How confident can we be when drawing conclusions about the 
effects of CBASP based on the validity and reliability of the existing research? 
 4) Are CBASP interventions acceptable to participants based on the 
dropout rates reported by the studies? 
 
3.3. Methods 
3.3.1. Registration of protocol 
 A protocol for the current review was submitted to the PROSPERO 
international prospective register of systematic reviews (CRD 42019151685). 
A copy of this protocol can be found in Appendix D. 
 
3.3.2. Search strategy 
 The following databases were searched from inception, with searches 
covering up to October 2019: Embase (1980 – October 2019), Medline (1946 
to October 2019), PsycInfo (1806 to October 2019), ASSiA (Social Science 
Premium Collection 1974 to October 2019) and CINAHL Plus (1937 – October 
2019). Searches sought to identify studies which reported the effects of a 
Cognitive Behavioural Analysis Systems of Psychotherapy (CBASP) on 
interpersonal functioning. Search terms included ("cognitive behavio* Analys*" 
or "cognitive-behavio* Analys* or CBASP) OR (("chronic* depress*" or 
"persist* depress*" or "recur* depress*") AND (therap* or intervention*) AND 
("cognitive behavio*" or "cognitive-behavio*")). Other appropriate search terms 
and filters as identified by the individual databases were also included. 
Reference lists of included studies were scanned for any additional relevant 
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studies. The leading authors in the area were contacted via e-mail to enquire 
about additional studies which were not identified by the databases. The 
search terms were consulted with the Academic Support Librarian at the 
University of Edinburgh in a meeting during which a number of search 
strategies were trialled. The search terms were purposefully not overly 
restrictive due to the limited amount of research in the area. The author 
decided to look specifically into the area of chronic and recurrent depression 
as this is the primary mental health diagnosis addressed by CBASP and the 
one which is included in the aforementioned national guidelines such as the 
Matrix or NICE under a separate entry. 
 
3.3.3. Inclusion/exclusion criteria 
 3.3.3.1. Inclusion criteria 
 Papers investigating the effects of CBASP intervention on 
interpersonal/social functioning were the focus of this review. The inclusion 
criteria stipulated that studies had to be published in English and involve a 
sample of adults (aged 18 and above) with a primary diagnosis of PDD, which 
was assessed before the intervention has commenced.  
For the purpose of the review, PD was defined as having been 
assessed and found to meet diagnostic criteria for PDD based on DSM-IV. 
Studies which included clinical samples who were highly likely to be affected 
by PDD, despite not meeting all of the DSM-IV criteria, were also included. 
The review included participants affected by: 
- chronic/persistent depression i.e. chronic MDD as per DSM-IV; double 
depression i.e. MDD/MDE as per DSM-IV/V superimposed on dysthymia as 
per DSM-IV; chronic MDD as per DSM-IV with the modification of at least one 
year as compared to two years of depressive symptoms; diagnosis of 
treatment-resistant depression defined as MDD as per DSM-IV/V criteria & 
lack of response to two trials of ADM's 
- recurrent MDD & being at risk of chronic depression: recurrent MDD as per 
DSM-IV/V with the minimum duration of the current episode six months; 
recurrent MDD as per DSM-IV/V with incomplete reemission between the 
episodes as per DSM-IV/V; recurrent MDD with the preceding episode no 
more than 2.5 years before the onset of the current episode 
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Interpersonal functioning was defined for the purpose of this review as 
social interaction and engagement within both intimate relationships and 
broader interpersonal situations. Included studies had to use a standardised 
measure or a subscale of a well-established measure of interpersonal 
functioning or social functioning and report the outcomes using inferential 
statistics. Both self-reported measures and clinician administered 
assessments were acceptable.  
The included studies had to investigate individual or group CBASP with 
no minimum or maximum number of sessions. Studies which investigated 
multiple treatment options were included if one of the treatments offered was 
CBASP. 
 
 3.3.3.2. Exclusion criteria  
 Studies were excluded if the diagnosis was established using a cut-off 
score on a measure of depression or if the used samples were non-clinical or 
the clinical diagnosis was not PD as described above. Studies using 
qualitative data and single case studies were also excluded. Non-peer 
reviewed papers including dissertations, book chapters and studies published 
in a language other than English were also excluded. 
 
3.3.4. Quality rating tool 
 As this review focused on studies which investigated the effects of 
CBASP intervention on psychological wellbeing, a quality rating measure that 
had been designed to assess intervention studies influencing public policy 
was chosen. The Effective Public Health Practice Project (EPHPP; Thomas, 
Ciliska,  Dobbins, & Micucci, 2004), a quality assessment tool for quantitative 
studies is a standardised tool which has been developed to ensure the high 
quality of systematic reviews investigating the evidence which can inform best 
practice within public health sector. The tool can be used to evaluate different 
types of intervention studies such as RCT's, before-and-after studies and 
case control studies. It has been judged to have suitable content and 
construct validity (Jackson & Waters, 2005; Thomas et al., 2004). EPHPP 
assists with an overall methodological rating of the studies across eight 
different domains i.e. selection bias, study design, confounders, blinding, data 
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collection methods, withdrawals and dropouts, intervention integrity and 
analysis. The first six of these domains can fall into a strong, moderate or 
weak category. These categories are then used to provide an overall rating. 
See Appendix E for the specifics of EPHPP quality rating tool. 
 
3.4. Results 
3.4.1. Search results 
 The initial literature search provided a total of 638 suggested studies 
(256 from Medline, 115 from Psychinfo, 102 from Embase, 118 from ASSIA, 
and 47 from CINHAL). An additional record was identified by scanning the 
reference lists in the relevant articles. Duplicates were removed which 
resulted in 313 studies. Studies were then further removed if their title had no 
relevance to the research question (e.g. related to nonhuman subjects, 
medical interventions, lack of intervention of interest etc.) or if the abstracts 
made it clear that the inclusion/exclusion criteria were not satisfied. Next, the 
full publication of the remaining 60 studies was downloaded and screened. 
After excluding another 52 studies due to a variety of reasons (see Figure 1 
below), eight papers were assessed as meeting the eligibility criteria. The vast 
majority of papers were rejected due to the lack of measure allowing to 
assess post-therapy changes within the interpersonal functioning among the 
chronically depressed patients which were the focus of this review. Since this 
review focused specifically on individuals affected by persistent depression, in 
order to enhance the evidence base indicating the benefits of CBASP for this 
population, a couple of studies which looked into disorders other than 
persistent depression were not included. An additional record was identified 
by scanning the reference lists in the relevant articles. The details of the 
search process are presented below as a flowchart (Figure 1). 
 
 Nine journal articles published between 2002 and 2018 met the 
inclusion and exclusion criteria. The included articles were obtained from the 
journals listed below: 
Behaviour Change (N=1); 
Biological Psychiatry (N=1); 
Depression and Anxiety (N=1); 
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European Archives of Psychiatry and Clinical Neuroscience (N=1); 
Journal of Affective Disorders (N=1); 
Journal of Clinical Psychology (N=1); 
Journal of Consulting and Clinical Psychology (N=1); 
Psychotherapy and Psychosomatics (N=2) 





















Figure 1. Prisma diagram showing search results; n (number of studies) 
Records identified through database 
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 A final number of studies included in 
qualitative synthesis including 
additional records identified through 
the reference lists 
(n = 9) 
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3.4.2. Data extraction 
 
 Data was extracted from the studies using a tool that was specifically 
designed for this review. Extraction data included author, year of publication, 
sample size, average age of participants, sample characteristics/setting, 
eligibility criteria, design and procedure, main outcome measures, attrition & 
statistical method, main outcomes, effect sizes and clinical significance, and 
follow-up data. Table 1 below presents a summary of the reviewed studies. 
 
 3.4.2.1. Main outcome measures 
The main outcome measures used by the authors of the included 
studies can be found in Appendix F which includes details of their validity and 
reliability. The main measures of social functioning used were: the Inventory 
of Interpersonal Problems (IIP-64/IIP-32; Horowitz, Alden, Wiggins, & Pincus, 
2000), the Impact Message Inventory (IMI-C; Kiesler & Schmidt, 2006),  the 
Social Adjustment Scale - Self-Report (SAS-SR; Weissman, 1999), the Social 
Adaptation Self-Evaluation Scale (SASS; Bosc, Dubini, & Polin, 1997), the 
Short Form Survey (SF-36; Ware & Sherbourne 1992), and the World Health 
Organization Quality of Life assessment (WHOQOL-BREF; Group, 1998). The 
main measures of depression used were: Beck's Depression Inventory (BDI; 
Beck, Steer, & Brown, 1996), Hamilton Depression Rating Scale (HAM-
D/HDRS; Hamilton, 1960), the Inventory of Depressive Symptomatology (IDS-
R; Rush, Gullion, Basoo, Jarrett, & Trivedi, 1996), and Montgomery-Asberg 
Depression Rating Scale (MADRS; Montgomery & Asberg, 1979). The Global 
Assessment of Functioning measure (GAF; American Psychiatric Association, 
1987) as well as the Patient Evaluation Form (PEF; Brakemeier, Strunk, 
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effects for social 
adjustment (F (2,612) = 
3.84, p < .002), and 
social functioning (F 
(2,526) = 3.71, p < .03). 
On SAS, CBASP+ADM 
superior to ADM, but no 
difference between 
CBPASP+ADM and 
CBASP, no difference 
between ADM and 
CBASP. On SF-36 
social functioning 
subscale, CBASP+ADM 
superior to ADM or 
CBASP alone, no 
difference between 
ADM and CBASP.  
 
Keller's et al. (2000) 
reported improvements 
on HAM-D across 3 
groups, with 
combination treatment 
being most effective. 
 
Large ES of 
CBASP (d=0.97) 
and CBASP+ADM 
(d=1.51) on SAS. 
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IPT, 1:1, 22 -
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Lack of main treatment 
effect on SASS 
 
Reduction of depressive 
symptoms as measured 
by HDRS in CBASP 
condition (t (13) = 3.53, 
p < 0.004), the effect of 
IPT on HDRS did not 
reach a statistical 
significance, no benefit 
of CBASP over IPT on 
HDRS, significant 
reduction in BDI scores 
in CBASP group (t (13) 
= 5.01, p < 0.001) and 
in IPT group (t (14) = 
2.34, p < 0.034  
 
Main treatment effect on 
GAF, both groups 
improved (CBASP: t 
(13) =-3.86, p = 0.002, 
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Social adjustment as 
measured by SAS 
improved (F (1,42) = 




measured by IIP-32 has 
not improved  
 
Gender did not 
moderate effects of 
treatment 
 
Symptoms on BDI 
decreased from severe 
to moderate level (F 
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Change on IMI, patients 
were perceived as more 
dominant (Ƅ = 0.73, 
SE=1.18, p < 0.001) 
and friendly (Ƅ = 0.85, 
SE=0.09, p < 0.001). 
They were also seen as 
Large ES of 
CBASP on HAM-
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less submissive and 
hostile. 
 
Scores on HAM-D 
decreased (SE = 1.01, p 
< .001) and on BDI 
decreased (SE= 1.78, p 
< .001) 
 
90.4% of the completers 
found the programme 
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Only ADM/CM group 
improved on SASS 
between weeks 1-8. No 
significant main effect or 
interaction found on 




At 28 weeks: 
Large ES of 
CBASP (d=0.98), 
medium ES of 
ADM/CM 
(d=0.50), large ES 
for ADM/CM+ 
CBASP (d=1.43) 
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scores as a 
covariate 
in depressive symptoms  
after 8 weeks as 
measured by MADRS χ² 
(1) = 12.20, p < 0.001, 
for both conditions For 
weeks 8-28, significant 
improvement for  
MADRS χ² (1) = 50.97, 
p < 0.001, for both 
conditions. 
Improvement also on 
IDS for both conditions. 
ADM+CBASP greater 
improvement between 
weeks 8-28, χ² (2) = 
11.22, p < 0.004 than 
monotherapy  
All groups improved 
between weeks 8-28 on 
GAF 
 
Small ES of 
CBASP (d=0.32), 
medium ES for 
ADM/CM 

































































































No significant effects of 
CBASP+TAU as 
compared to TAU on 
SASS and SF-36. 
 
MBCT+TAU different 
significantly from TAU 
on SASS measure 
(Ƅ=2.43, SE=1.01, p < 
0.05)  
 
Medium ES of 
MBCT on SASS 
(d=0.57) 
 
Large ES of 
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Decrease in depressive 
symptoms on HAM-D in 
all 3 treatment 
conditions. 
CBASP+TAU led to a 
significantly greater 
decrease on HAM-D 
than TAU and 
MBCT+TAU. Decrease 
in depressive symptoms 
as measured by BDI in 
CBASP+ TAU and 
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decreased in CBASP 
groups (bs= -.094, 
SEs=.037; bs=-.209, SEs 
0.47) but not in BA 
groups. Other types of 


















































































as measured by IIP 








than BA treatment (Ƅ=-
5.697, SE=0.688, p≤ 
.01) as measured by 
HDRS 
Self-reported changes 
in depressive symptoms 
as measured by BDI, 
although significant, did 






















































































in patients' subjective 
quality of life as 
measured by 
WHOQOL-BREF (t 
(489) =-5.88, p ≤ 0.001). 
The improvement was 
significant across the 
subscales, including 
social relationships 
subscale (p < 0.01).  
 
Large ES of 
CBASP on HDRS 



















































As measured by HDRS-
24 and BDI, significant 
improvement over time 
(t (3226) = 12.71, p ≤ 
.001; t (386) = 10.40, p 
≤ .001). 
 
As measured by PEF, 
patient's acceptance 
increased over the 
course of group therapy 
(t (69) = 6.70, p≤ 0.001, 
d=0.60). Patients gave 
CBASP psychotherapy 
overall mark of 2 (good) 
on a scale from 1 (very 
good) to 6 
(unsatisfactory). The 
majority of patients 
(75.3%) felt that CBASP 












































































For IIP-64, significant 
interaction between the 
treatment group and AD 
(F (1,221) = 8.81, p= 
0.003).  While both 
treatments produced 
improvements, patients 
with AD showed 
significantly less 
interpersonal problems 
ES of CBASP on 
IIP for patients 
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Diagnosis of AD had a 
moderating effect on 
treatment efficacy, the 
interaction between the 
treatment group and AD 
was significant (F (1, 
256) =7.06, p=0.01). 
While both treatments 
produced improvement, 
patients with AD had a 
significantly lower 
HDRS score after 20 
weeks if they were 
treated with CBASP 
rather than with SP.  
 
the remission rate 
for patients with 
AD higher in the 
CBASP group vs 




Abbreviations: AD (anxiety disorders), ADM (antidepressant medication), BA (Behavioural Activation), CBASP(Cognitive Behavioural Analysis of Psychotherapy), 
CD (chronic depression),  CM (clinical management), DV's (dependent variables), DD (double depression), ES (effect size), IPT (Interpersonal Therapy), MBCT 
(Mindfulness-Based Cognitive Therapy), MDD (Major Depressive Disorder), MDE (Major Depressive Episode), MDT (multidisciplinary), N (sample size), PDD 
(Persistent Depressive Disorder), RCT/RT (randomised controlled trial/ randomised trial), SD (standard deviation), SP (supportive therapy),TAU (treatment as 
usual), W/L (waiting list). Measures: BDI-II (Beck's Depression Inventory; Beck, Steer, & Brown, 1996), GAF (Global Assessment of Functioning; American 
Psychiatric Association, 1987), HAM-D/HDRS (Hamilton Depression Rating Scale; Hamilton, 1960), IDS (Inventory of Depressive Symptomatology; Rush, 
Gullion, Basoo, Jarrett, & Trivedi, 1996), IIP (Inventory of Interpersonal Problems; Horowitz, Alden, Wiggins, & Pincus, 2000), IMI-C (Impact Message Inventory; 
Kiesler & Schmidt, 2006), MADRS (Montgomery-Asberg Depression Rating Scale; Montgomery & Asberg, 1979), PEF (Patient Evaluation Form; Brakemeier, 
Strunk, Normann, & Schramm, 2010), SAS-SR (Social Adjustment Scale-Self Report; Weissman, 1999), SASS (Social Adaptation Self-Evaluation Scale; Bosc, 
Dubini, & Polin, 1997), SF-36 (Short Form Survey; Ware & Sherbourne, 1992), WHOQOL-BREF(World Health Organization Quality of Life Assessment; Group, 
1998)  
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3.4.3. Studies published by the same author/authors 
Three studies included in the review were published by the same 
leading author (Schramm et al., 2011; Schramm et al., 2015; Assman et al., 
2018 (this was secondary analysis based on study by Schramm et al., 2017)). 
In the context of limited number of studies which were included in the review, 
it seems important to discuss potential bias resulting from a phenomenon 
known as researcher allegiance. Researcher allegiance has been defined as 
‘the belief in superiority of an intervention and of the superior validity of the 
theory of change that is associated with the treatment’ (Leykin & DeRubeis 
2009). Elizabeth Schramm is known for her expertise on CBASP and is a co-
author of a book titled ‘CBASP as a distinctive treatment for Persistent 
Depressive Disorder’ (McCullough, Schramm, & Penberthy, 2014). It has 
been suggested that strong commitment to a particular type of therapy might 
unintentionally affect the results of studies by affecting researcher’s 
judgement, interpretation of the findings or lead to a bias in methodology 
(Munder, Bruetsch, Leonhart, Gerger, & Barth, 2013). Bearing the risk of 
researcher allegiance in mind, it is worth noting that the three studies 
associated with Schramm have been rated as ‘strong’ and varied in their 
methodology which resulted in interesting and novel findings. 
 
3.4.4. Conceptualisation of PD 
 While the above nine studies slightly differed in terms of criteria used to 
diagnose PD, all of them referred to DSM-IV/DSM-V criteria for MDD, MDE, 
CD or PDD. Six out of nine studies included participants who had either a 
diagnosis of MDD, MDD/MDE superimposed on dysthymia, or recurrent MDD 
with the current symptoms lasting two or more years. One of the studies 
(Schramm et al., 2015) defined PDD by modifying the standard criterion of 
depressive symptoms lasting at least two years, and included individuals who 
were affected by MDD for at least a year, or who reported recurrent MDD 
(three or more episodes). Although there was no guarantee that this study 
recruited subjects affected by PDD, the minimum duration of an episode 
and/or recurrent nature of symptoms made the reported symptoms likely to be 
either chronic or develop into PDD in the near future. Another study 
(Brakemeier et al., 2015) used criteria of treatment-resistant depression, 
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which required a diagnosis of MDD and a lack of response to two trials of 
ADM's. While the study did not specify a minimum length of an episode, the 
authors have reported that an average duration of an episode reported by 
participants was two years and seven months. Given this average duration of 
an episode and the time that is usually required to diagnose a person with 
MDD and implement two trials of medication, it was assumed that the 
episodes were likely to be of chronic nature. In the study by Locke et al. 
(2017), participants had to have a diagnosis of MDD with a minimum duration 
of an episode set at six months and be at risk of PDD i.e. 82.8% had a 
previously diagnosed depressive episode (median number of previous 
episodes: three). 
 
3.4.5. Methodological evaluation 
 Each of the nine articles were read multiple times and were 
subsequently assessed using the EPHPP evaluation tool (Thomas et al., 
2004) by the first author. A fellow doctoral trainee was then asked to review 
five out of nine studies (55.5%) in order to establish the quality of the 
assessment. Inter-rater agreement was found to be excellent with Cohen's 
kappa of 97% (Cohen, 1960) which was in line with the research findings 
suggesting fair to excellent agreement between raters across different 
domains of EPHP (Armijo-Olivo, Stiles, Hagen, Biondo, Cummings, 2012). 
The disagreements with the independent rater were relatively easy to resolve 
through a discussion as they focused on the psychometric properties of the 
measures used in the studies, which while well established in the literature, 
were unclear to the independent rater due to lack of clarity in the reporting. A 
summary of the EPHPP quality ratings can be found in Table 2 below. The 
following section further discusses the results of the EPHPP evaluation for the 
nine intervention outcome studies. The areas of evaluation discussed will be 





Summary of the EPHPP evaluation with additional information regarding the use of statistics 
 
 



















et al., 2002 
moderate strong strong moderate moderate moderate moderate appropriate yes not reported strong 
2. Schramm 
et al., 2011 
moderate strong strong moderate moderate strong strong appropriate yes underpowered strong 
3. Sayegh et 
al., 2012 
moderate moderate strong weak strong strong strong appropriate no dropouts not reported moderate 
4. Brakemeier 
et al., 2015 
moderate moderate strong weak moderate strong strong appropriate yes not reported moderate 
5.Schramm et 
al., 2015 
moderate strong strong moderate strong strong strong appropriate yes underpowered strong 
6. Michalak et 
al. 2015 
moderate strong strong moderate moderate moderate moderate appropriate yes underpowered strong 
7. Locke et 
al., 2017 
moderate strong weak moderate moderate weak weak appropriate not reported not reported weak 
8. Sabaß et 
al., 2018 
moderate moderate strong weak moderate strong weak appropriate yes not reported moderate 
9. Assman et 
al., 2018 




3.4.6. Risk of selection bias 
 In order to recruit participants to the studies, the authors relied on 
opportunity sampling. They either invited individuals who were known to be 
affected by depression in outpatient or inpatient settings to take part in the 
study or advertised the study in the community. The main difficulty with 
opportunity sampling is that the sample is not randomly selected, and 
therefore, it is likely to be biased. Furthermore, such samples often represent 
very specific populations (community members or patients who are motivated 
and well enough to participate) which might not be highly representative of the 
population affected by PDD as a whole. In addition, no study reported how 
many of the approached individuals or the individuals who expressed an initial 
interest consented to take part in the study. For the above reasons, all nine 
studies were rated as 'moderate' on the item assessing risk of selection bias.  
 
3.4.7. Study design 
 Although RCT's are the gold standard for exploring causal relationships 
between interventions and outcomes, only six out of the nine evaluated 
studies both used a control/comparison group and randomised participants 
into different conditions. The studies were rated as 'strong' on the study 
design item. The other three studies, which used cohort design comparing the 
same group of subjects before and after the intervention, were rated as 
'moderate'. Importantly, the process of randomisation which balances 
participants’ characteristics between the groups helps to reduce bias when 
examining cause and effect relationships. The RCT design allows a greater 
degree of certainty when drawing conclusions about the outcomes of the 
interventions by allowing attribution of any changes within outcomes to the 
actual intervention. Importantly, out of the six RCT studies, four used 
TAU/SP/IPT/MBCT/BA interventions and two ADM as comparison conditions. 
Designing a study with an appropriate control group can be particularly 
challenging for studies involving participants with a mental health condition. 
Withdrawing or delaying treatment can be seen as unethical and it is also 
likely to lead to a higher dropout among the subjects. Nevertheless, the lack of 
appropriate control condition makes the interpretation of the results more 
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difficult due to potential confounding variables that might be influencing the 
outcomes e.g. talking to a therapist. 
 
3.4.8. Confounders 
 Overall, attempts made by authors to control for confounding variables 
(which the EPHPP defines as differences between groups pre-intervention) 
which can be seen as a potential threat to the study validity were assessed as 
'strong', except for one study which did not report a baseline comparison 
between treatment groups on standard demographic variables and for that 
reason was assessed as weak. The majority of the studies run analyses 
comparing participants across conditions on characteristics such as age, 
gender, marital status, employment and education history. Some studies also 
included additional variables such as severity of depression, comorbidities, 
medication intake, and psychotherapy attendance. Importantly, the majority of 
analyses showed no differences between the groups on tested variables. If 
differences were found, they were controlled for using statistical methods. For 
the two studies which used a cohort design with one study condition, the 
problems associated with between-groups differences were not relevant. 
 
3.4.9. Blinding 
 Six out of nine studies ensured that the outcome measures were 
collected by a member of the research team who was unaware of the 
condition the participant was allocated to. However, due to the fact that it is 
impossible to blind therapists to the intervention they deliver and fully blind the 
subjects as to what condition they participate in, these six studies were rated 
as 'moderate' on the 'blinding' item. The remaining three studies were cohort 
studies and by the virtue of their design blinding was difficult, and therefore 
they were rated as 'weak'. 
 
3.4.10. Data collection method 
 Both reliability and validity of the used measures were judged as 
'strong' for only two out of nine studies. The main questionnaires used by 
these authors are well-established and have strong psychometric properties 
(see Appendix G). Seven studies which incorporated the HAM-D/HRSD, 
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clinician-administered measure, were assessed as 'moderate' due to research 
indicating poor psychometric properties of this particular scale. However, it is 
also worth bearing in mind that most outcome scores were assessed using 
self-report measures only, and therefore the clinician-administered scales 
such as HAM-D, IMI and GAF can be a valuable source of data. It would have 
been useful if the authors of each study used reliable and valid clinician-
administered measures or interviewed the participants to increase accuracy of 
the assessment. 
 Importantly, evaluated studies used a number of different measures to 
assess variables of interest. In order to assess depression, seven studies 
have used HAM-D/HRSD, six studies used BDI, and one study used MADRS 
and IDS. In order to assess interpersonal functioning/social functioning, three 
studies used IIP measuring interpersonal problems, three studies used SAAS 
measuring social adaptation, two studies used SAS-SR measuring social 
adjustment, and one study used clinician-rated IMI measuring interpersonal 
style. Two studies used social functioning subscale of SF-36 and one study 
used social relationships subscale of WHOQL-BREF. The use of different 
subscales makes it more difficult to compare the results across the studies as 
there is no certainty that the studies are indeed evaluating the same 
conceptual constructs. It is also worth remembering that the psychometric 
properties of the measures are often based on the full scale, and therefore, in 
order to increase reliability and validity of the findings, it may be more useful 
to rely on the full scale rather than a subscale of a measure that was designed 
to capture a wider concept. 
 
3.4.11. Withdrawals and dropouts 
 The majority of the studies have reported the rate of withdrawals and 
dropouts after assigning participants to the study condition. The rate of 
withdrawal and dropouts was well documented and relatively low (less than 
20%) for six studies which were assigned a 'strong' rating. Two studies 
reported significantly higher withdrawal and dropout rates (more than 20%) 
which led to a 'moderate' rating. One study did not report on this item, and 
therefore received a 'weak' rating. Without information on dropout rates, it can 
be difficult to assess how biased the final sample was. 
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The drop-out rate in CBASP conditions was calculated to be between 
0% and 29% with an average rate of approx. 12% (14% at the level of a 
study). Such dropout rates are seen as not unusual when compared to other 
studies assessing the effects of a therapeutic intervention, indicating that the 
CBASP intervention is indeed feasible. In fact, a meta-analysis of dropout 
rates in studies involving outpatient psychotherapy for MDD revealed an 
average rate of discontinuation of 19.9% (Cooper & Conklin, 2015). Higher 
dropout rates were reported to be associated with comorbid personality 
disorders or a minority racial status which might also be a potential 
explanation behind the heterogeneity of the dropout rates among the studies 
in this review.    
 Importantly, the unequal loss of participants in clinical studies can lead 
to attrition bias. Participants can withdraw for a variety of reasons or they 
might be excluded due to, for example, the violation of the study protocol. 
Such drop-outs can affect the power of the study and lead to the differences 
between the groups. To overcome the attrition bias and as a way of dealing 
with missing data, intention to treat analysis (ITT) has been introduced as part 
of the statistical computations (McCoy, 2017). Intention to treat analysis 
allows all the patients who were randomised into the trial to be included in the 
final analysis. As part of ITT end-point values need to be estimated of the lost 
patients or data points. A number of approaches have been developed to 
estimate these data including ‘last observation carried forward’ analysis and 
multiple imputation. Seven out of nine studies have used either of these 
techniques. The remaining two studies (Locke et al., 2007; Sayegh et al., 
2012) did not report on how they handled attrition or missing data. 
  
 
3.4.12. Overall ratings 
 The overall ratings assigned to each study are based on the above six 
quality rating items. To summarise, five studies have been assigned a 'strong' 
rating, three studies have been assigned a 'moderate' rating and one study 




3.4.13. Additional evaluations 
 There are two additional rating items on the EPHPP i.e. integrity of the 
intervention and statistical analysis which do not contribute to the overall 
evaluation and do not have an official rating scale, but can be seen as equally 
important when assessing the validity of the study, and therefore have been 
assessed by the author of this review. 
 
3.4.14. Integrity of the intervention 
 The majority of the studies (five out of nine) were rated as 'strong' on 
this item as they reported a method of measuring the consistency of the 
intervention delivered and the dropouts within the condition delivering the 
intervention of interest were under 20%. Two studies have been rated as 
'moderate' due to a relatively high dropout rate. One of the studies did not 
report on the method of ensuring consistency, and despite acceptable dropout 
rates, was rated as 'weak'. Another study which was rated as 'weak' did not 
report the dropout rates at all. While there was no evidence of an 'unintended 
intervention' that might have influenced the results, only the studies with an 
appropriate control group can claim with a high degree of certainty that it was, 
in fact, CBASP intervention that has led to the changes in the measured 
outcomes. 
 
3.4.15. Statistical analysis 
 The studies have been assessed as using appropriate and well-justified 
statistical analyses. However, the validity of the analyses was threatened 
across the studies due to insufficient power or power not being reported. It is 
worth remembering that a small sample can increase the chance of type II 
error resulting in significant outcomes not being detected due to low statistical 
power. The presentation of test results across the studies was acceptable, 
with the majority of the studies reporting t/F values, p values and degrees of 
freedom. It is worth noting that seven out of nine studies reported effect sizes 






 Does CBASP intervention improve interpersonal functioning in 
individuals affected by PD? 
Does CBASP intervention reduce depressive symptoms in individuals 
affected by PD? 
 Are CBASP interventions acceptable to participants based on the 
dropout rates reported by the studies? 
 
Please see the Table 3 below which summarises the main outcomes for each 





Notes: CBASP was the intervention delivered in all studies, in the study marked * CBASP + TAU was used; Abbreviations: AD (anxiety disorders), ADM 
(antidepressant medication), BA (Behavioural Activation), CBASP(Cognitive Behavioural Analysis of Psychotherapy), CM (clinical management), IPT 
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Adjustment Scale-Self Report; Weissman, 1999), SASS (Social Adaptation Self-Evaluation Scale; Bosc, Dubini, & Polin, 1997), SF-36 (Short Form Survey; Ware 





3.4.16.1. CBASP and outcomes on interpersonal/social functioning 
 Six out of nine studies revealed a significant effect of CBASP 
intervention on at least one of the measures assessing interpersonal/social 
functioning they used. Two studies (Assman et al., 2018; Locke et al., 2017) 
found a significant improvement on interpersonal functioning as measured by 
IIP. Two studies (Hirschfield et al., 2002; Sayegh et al., 2012) reported a 
significant effect of CBASP on social adjustment measured by SAS. 
Additionally, a study by Hirschfield et al. (2002) found an improvement on 
social functioning measured by SF-36. A study by Brakemeier et al. (2015) 
found patients to be more dominant and friendly following the intervention as 
shown by the IMI. There was a significant change within social relationships 
as measured by a subscale of the WHOQOL questionnaire used by Sabaß et 
al. (2018). 
 Three studies (Michalak et al., 2015; Schramm, 2011; Schramm et al., 
2015) which used SASS as an outcome measure found no change, 
suggesting either the lack of improvement in the areas of social functioning, or 
that this particular questionnaire did not capture the processes targeted by 
CBASP. One of the studies (Michalak et al., 2015) which used SF-36 
alongside SAAS found lack of improvement on both of the measures. 
 A number of studies compared the effects of CBASP with an alternative 
intervention. A study by Hirschfield et al. (2002) revealed a benefit of a 
combined intervention (CBASP + ADM) over medication on both SF-36 and 
SAS measures. A study by Locke et al. (2017) revealed the benefit of CBASP 
over BA on some but not all aspects measured by IIP (an increase in 
assertiveness and a decrease in agreeableness). In the study by Assman and 
colleagues (2018) patients treated by CBASP as opposed to SP have 
experienced more positive changes within interpersonal functioning only if 
they had a comorbid diagnosis of AD. Importantly, Schramm et al. (2011) and 
Michalak et al.( 2015) failed to demonstrate the effects of CBASP on the 
interpersonal/social outcomes, or its superiority over IPT or MBCT 
respectively. In fact, MBCT led to a significant change on the SASS measure 
as compared to CBASP intervention which had no effect. 
 It has become standard practice to determine effect sizes when 
reporting the results of the intervention (Kirk, 1996). Effect size indicates the 
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magnitude of the difference between the groups. Three out of nine studies 
reported effect sizes (see Table 1) , which ranged from small to large, 
illustrating the magnitude of the change within the interpersonal functioning 
following CBASP intervention as assessed by three different measures (IIP, 
SAS and IMI). 
 Importantly, the two studies which assessed the clinical significance of 
the changes observed within the interpersonal domain following the CBASP 
intervention reported that the levels of social functioning post-treatment were 
still significantly higher compared to those of the normative samples. 
Hirschfield and colleagues (2002) reported that psychosocial functioning at 
the end point was one standard deviation worse than the community norm. 
The process of establishing clinical significance requires the use of reliable 
measures that are indicative of norms for a typically functioning population, 
and thus can be challenging. Nevertheless, it is of great importance to do so 
as determining clinical significance enhances credibility of the observed 
effects and is indicative of the magnitude of the effect the intervention had on 
the participants' daily life. 
Six different measures were used to assess aspects of 
interpersonal/social functioning (IIP, SAAS, SAS, IMI, and subscales of SF 
and WHOQOL). It is possible that a considerable variance between the 
measures used yielded different results due to them assessing a range of 
different concepts. For example, the IIP assesses a number of aspects 
associated with interpersonal functioning such as sociability, assertiveness, 
aggression, supportiveness, involvement, caring, openness and dependency. 
CBASP aims to increase patients' understanding of the functionality of their 
behaviours and sense of control. Specific techniques in CBASP also help the 
person to move from the socially avoidant/hostile submissive position towards 
a more assertive and friendly one. Therefore, one might expect the changes 
within the areas measured by the IIP. In fact, two out of three studies which 
have used the IIP as a measure found an improvement within interpersonal 
functioning following CBASP intervention. In contrast, three studies which 
used SASS, a scale which is used to assess social motivation and behaviour 




 3.4.16.2. CBASP and outcomes on depression measures 
 All of the nine studies revealed a significant effect of CBASP 
intervention on depressive symptoms as assessed by both self-report and 
clinician-administered measures. The preliminary evidence from three studies 
(Locke et al, 2015; Michalak et al., 2015; Schramm et al., 2011) indicated the 
benefit of CBASP over alternative interventions recommended for depression 
such as IPT, MBCT and BA. It is worth noting that the benefit of CBASP as 
compared to MBCT was demonstrated on HAM-D but not BDI measure. The 
study by Hirschfield et al. (2002) and Schramm et al. (2015) demonstrated 
that the combined treatment of CBASP and ADM was superior to CBASP 
alone on measures of depression. Study by Assman et al. (2018) found 
CBASP to be more effective in reducing depressive symptoms when treating 
patients with comorbid AD. Seven out of nine studies reported effect sizes of 
CBASP on depressive symptoms which ranged from small to large. In order to 
assess the clinical significance of the observed changes within the depressive 
symptomatology, six out nine studies reported remission rates, which in 
CBASP conditions oscillated between 25.7% and 57%. 
 
 3.4.16.3. Outcomes at follow-up 
 Outcomes at follow-up were reported by three studies only and were 
inconsistent. Two studies (Brakemeier et al., 2015; Schramm et al., 2011) 
have reported follow-up results at 1 year and one study (Bausch et al., 2017) 
at four and a half years post-treatment, with only one of these studies 
including a measure of social functioning. While Schramm et al. (2011) have 
shown that the effects of CBASP on depression and social functioning were 
maintained, Brakemeier et al. (2015) have shown that slightly more than a half 
of completers (52%) relapsed, with the remaining 48% sustaining a response 
to treatment as measured by changes within depressive symptoms. Finally, a 
study by Schramm et al. (2015) revealed a significant increase in reported 
depressive symptoms.  
It is worth noting that such results suggesting that roughly half of the 
patients report long-lasting effects of the treatment are not unusual. While 
several studies indicated the medium-term effectiveness (6months-1year) of 
 51 
CBT for depression (Hollon et al., 2005; Kovacs, Rush, Beck, & Hollon, 1981; 
Miller, Norman, & Keitner, 1989), the sample sizes included in the studies 
were often relatively small (75 per treatment condition) which limited the 
generalizability of the findings. A large trial on the effectiveness of CBT 
delivered alongside usual care (that included antidepressants) on treatment 
resistant depression carried out in 2013 by Wiles and colleagues (2012), 
involved 469 patients with 235 patients being assigned to treatment as usual 
and 234 patients to CBT plus treatment as usual. Ninety percent of the 
patients were followed up at 6 months and 84% at 12 months. The authors 
have found that 46% of the patient in the CBT group met criteria for response 
(50% reduction in depressive symptoms) at 6 months as compared to 22% of 
patients in the treatment as usual group. The benefits were maintained at 12 
months.  
 
3.4.16.4. Delivery of CBASP 
 Across the studies, CBASP intervention was delivered in different ways 
using manuals for individual therapy, group therapy and a specific CBASP 
programme within an inpatient setting. Four out of nine studies delivered 
CBASP in a 1:1 setting with a number of sessions ranging from 16 to 32. Four 
studies delivered CBASP in a group setting with the number of sessions 
ranging from eight to 20. Three out of these four studies offered participants 
between two to four individual sessions prior to starting the group in order to 
work out a transference hypothesis which is part of CBASP treatment. One 
study delivered an inpatient programme consisting of a combination of 
individual, group and an multidisciplinary input, and did not report the exact 
number of sessions provided. It is worth pointing out that while there does not 
seem to be a pattern suggesting that one way of delivery is more beneficial 
than the other, more studies exploring the effects of CBASP are needed to be 
able to make valid comparisons. 
 
3.5. Discussion 
3.5.1. Summary of findings 
 The present review focused on improvements in the area of social 
functioning, showing promising results. The majority of the reviewed studies 
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have revealed the improvements on the measures of interpersonal 
functioning, and all of the studies reported improvements in depressive 
symptoms following the CBASP intervention. Only six out of the nine reviewed 
studies used an alternative intervention as a comparison group to CBASP 
condition. Due to the small number of studies and mixed results, the findings 
with regards to the effectiveness of CBASP as compared to alternative 
interventions are somewhat inconclusive. 
 The changes in depressive symptoms following CBASP intervention 
found in this review are in line with the findings from a meta-analysis by Negt 
et al. (2016) adding to the evidence indicating that CBASP is effective in 
treating PD. While the reduction in depressive symptoms took place across all 
of the studies, only six out of nine papers have revealed positive outcomes in 
the area of interpersonal functioning. Importantly, there was a high degree of 
variation in how interpersonal functioning was defined and measured across 
the studies making the findings difficult to compare. It is possible that while 
CBASP improves aspects of interpersonal functioning such as assertiveness 
or dependency measured by IIP, it does not have an immediate impact on the 
broader social functioning associated with work, home life, friends and 
hobbies, as measured by SASS, which might take more time to change. 
Interestingly, the study by Weissman, Olfson, Gameroff, Feder, & Fuentes 
(2001) which compared the SF-36, SASS and SAS revealed that while the 
scales were able to differentiate between clinical and non-clinical populations, 
there was only modest correlation between them suggesting that they might 
be measuring slightly different concepts. It might be helpful in the future to use 
multiple well-established scales in the same study in order to assess the exact 
aspects of social functioning that change as a result of CBASP intervention. 
 A more consistent approach was visible regarding the assessment of 
depressive symptoms, perhaps due to the relative clarity of the definition of 
depression. Six out of nine studies used BDI as a measure of depression, with 
the remaining studies using either clinician-administered outcome measures 
or alternative self-report measures (e.g. IDS). The use of measures assessing 
similar, if not the same, concepts allowed the researchers to demonstrate the 
improvements in the specific symptoms of depression across the studies. 
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 Research findings suggest that individuals with severe interpersonal 
difficulties can be more reluctant to change (Borkovec, Newman, Pincus, & 
Lytle, 2002; Gurtman, 1996; 2002; Muran, Segal, Samstag, & Crawford, 
1994). Difficulties with being assertive and not attending to one's own needs 
have also been found to correlate with higher levels of depressive symptoms 
post-treatment (McEvoy et al., 2013) and are associated with poorer treatment 
outcomes in subjects with generalised anxiety disorder (Borkovec et al., 2002) 
and depression (Hardy et al., 2001). It is possible that participants included in 
the studies which showed no improvement in interpersonal or social 
functioning were affected by particularly severe interpersonal difficulties.   
 Interestingly, a study by Assman et al. (2018) indicated that CBASP 
treatment might be particularly useful for chronically depressed individuals 
who suffer from comorbid AD. The authors found that CBASP was superior to 
SP only for those participants who reported anxiety alongside depression. 
Furhter analysis showed that the superiority of CBASP over SP was 
demonstrated only for the individuals struggling primarily with social anxiety. It 
is possible that even though CBASP was developed specifically for chronic 
depression, the techniques it uses help to target a number of transdiagnostic 
psychological mechanisms which are likely to be implicated in a number of 
other disorders including social anxiety (Rodebaugh, Holaway, & Heimberg, 
2004). For example, CBASP aims to increase one's awareness of the effects 
the individual's behaviours have on others, with the hope that this will lead to 
an increase in satisfactory relationships. A person who has learned to pay 
more attention to particular aspects of the interactions as they happen, might 
also be less likely to ruminate on their negative thoughts, which in turn can 
lead to a reduction in anxiety.  
 Importantly, the dropout rates for the included studies indicated that 
CBASP is an intervention that is acceptable to patients. Furthermore, 90.4% 
of the completers in the study by Brakemeier et al. (2015) found the 
intervention 'helpful' or 'very helpful', while the study by Sabaß et al. (2018) 
revealed that, on average, the patients rated the group version of the 
intervention in the inpatient setting as 'good'. Five out of nine included studies 
have designed their interventions to be viable in group settings. It is worth 
pointing out that stepped care models of service delivery recommended by the 
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National Institute for Health and Care Excellence (2011) encourage access to 
lower intensity psychological interventions, such as cognitive-behavioural 
groups, as they can often reach a large audience at a lower cost.  Indeed, 
CBASP lends itself very well to a group setting given the interpersonal focus 
of the intervention. In a group setting, positive and negative reinforcements 
can be provided by peers and reflected on with the guidance from the 
facilitator. Group therapy for depression has been shown to be equivalent or 
marginally less effective (only in short-term) when compared to individual 
therapy (Cuijpers, Van Straten, & Warmerdam, 2008) while its cost has been 
shown to be less than half of that of one-to-one therapy (Vos, Corry, Haby, 
Carter, & Andrews, 2005). Group settings might also be particularly useful 
when developing post-treatment continuation and maintenance support 
groups aimed at treatment resistant depression or reducing the likelihood of 
relapse. Research comparing individual and group interventions could help 
services to choose the most suitable modes of therapy that meet patients' 
needs. Further research into the effects of individual and group CBASP on 
patient's mental health is likely to contribute to more cost effective and refined 
interventions for PD. 
 Only two out of nine reviewed studies (Schramm et al., 2011; 
Brakemeier et al., 2015) have reported follow-up results and only one of them 
included a measure of social functioning at that stage. The findings were 
mixed, suggesting that a significant number of patients might relapse a year 
after the intervention. Due to the lack of substantial data, these findings 
should be interpreted with caution. It has been suggested before, that in order 
to maintain the benefits of therapy for chronic depression, long-term courses 
of psychological intervention might be helpful (Conradi et al., 2007; Cuijpers et 
al., 2010b). 
 It is also worth noting that the present review focused on the individuals 
affected by PDD i.e. the population CBASP was specifically developed for. In 
the light of new evidence, suggesting that CBASP may be effective when 
used as a preventative intervention or trauma intervention (Braithwaite, Scott, 
Fincham & Frank, 2000; Favorite, Messina, Smith, & Porcari), it could be 
helpful to review the evidence with other clinical and non-clinical populations.  
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3.5.2. Quality of evidence 
 
How confident can we be when drawing conclusions about the effects of 
CBASP based on the validity and reliability of the existing research? 
 
 Although the findings from this review provide preliminary evidence for 
the effectiveness of CBASP on interpersonal functioning and depressive 
symptoms, validity and reliability of the results can be seen as somewhat 
limited.  
 In terms of the methodological quality, the studies under investigation 
have been shown to be of a good standard with an overall strong or moderate 
rating assigned to eight out of nine studies. Only one study received a weak 
rating; it was also the only study that did not report dropout and withdrawal 
rates. The majority of the studies adopted randomised designs, used cohorts 
that can be seen as, overall, representative of the patients in the healthcare 
system, and used appropriate data collection methods with suitable statistical 
analyses. A good methodological quality across the studies ensured reliability 
and validity of the results. Nonetheless, a number of limitations to the current 
body of research investigating the effects of CBASP on interpersonal 
functioning and depression have been uncovered in this review.  
 Only six of the above studies have been designed as RCT's with TAU 
(or an alternative intervention) acting as a control/comparison group. The lack 
of a suitable comparison group in the majority of the studies introduces a 
number of questions with the regards to the mechanisms of change that were 
responsible for the positive outcomes. It cannot be stated with confidence that 
the changes within depressive symptoms and interpersonal functioning were a 
result of CBASP as opposed to nonspecific psychosocial ingredients of other 
interventions. The two studies which compared CBASP to non-specific 
intervention (TAU and SP) produced inconsistent results which makes the 
interpretations of the findings difficult.  
 Somewhat surprisingly, none of the studies demonstrated sufficient 
power which threatened the overall validity of the analyses. Four studies were 
underpowered with the remaining five neglecting to discuss this issue. It is 
possible that the effects of CBASP on interpersonal functioning have not been 
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detected in three out of nine studies simply due to the insufficient number of 
participants. While difficulties with recruitment of depressed patients have 
been documented in the past (Hughes-Morley, Young, Waheed, Small, 
& Bower, 2015), it is essential for the researchers to calculate required sample 
size a priori and aim to recruit enough participants to be able to increase the 
validity of supported hypotheses. 
Another variation between the studies, which made comparisons more 
difficult, were the differences between treatment protocols. Five of the studies 
reported delivering CBASP in a group setting which has proven to be a 
popular approach in the healthcare services as it maximises the number of 
patients that can be seen at any one given time. However, due to the 
somewhat inconsistent methods of treatment delivery and a substantial 
variation in the number of sessions delivered in each study (with the number 
of sessions available to the patient ranging from 8 to 32), it is likely that the 
differences between the outcomes across the studies can be partially 
explained by the variation in the treatments offered to patients. It has been 
found that at least 18 sessions are required for patients with PDD in order for 
them to benefit from the optimal effects of psychological intervention (Cuijpers 
et al., 2010b). Research has also shown that the initial stage of CBASP 
therapy may in fact lead to a deterioration, given the often traumatic nature of 
the experiences discussed (Brakemeier et al., 2015). Indeed, study by 
Michalak et al. (2015), which showed no benefit of CBASP over TAU, included 
only 10 sessions of CBASP, out of which only the first two were offered on 
one to one basis.  
   
 3.5.3. Limitation of the current review and implications for the future 
research 
 This review has a number of limitations. Due to a relatively small 
number of studies investigating CBASP intervention (as compared to, for 
example, CBT), and even fewer using measures of interpersonal functioning 
while investigating the population affected by PDD, these findings have to be 
interpreted with a degree of caution in terms of their generalisability. 
Furthermore, all of the included studies relied on similar qualitative 
methodology limiting the richness of data it produced. Hopefully, future studies 
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investigating interpersonal functioning and associated mechanisms of change 
will employ more varied designs including, for example, qualitative methods of 
data collection. It is also worth bearing in mind that research which shows the 
significant effects of clinical interventions is more likely to be published in 
scientific journals (Hemingway & Brereton, 2009) which might have led to 
publication bias. 
 It seems that while empirical base supporting CBASP as an 
intervention for PD is growing, the specific mechanisms of change have not 
been fully explained. Given McCullough's theory suggesting the mediating 
role of cognitive-emotional development and interpersonal functioning 
between trauma and PD, more researchers should focus on investigating 
these two factors. In fact, it is somewhat surprising that only nine articles have 
met the inclusion criteria for this review. In the future, it would have been 
useful for CBASP studies to include IIP measure as a standard assessment of 
interpersonal functioning alongside other measures assessing different 
aspects of this broad construct. Being able to form and develop interpersonal 
relationships has been discussed as the cornerstone of happiness and 
wellbeing while difficulties in this area have been found to be associated not 
only with depression but also with anxiety, eating disorders and personality 
disorders. Future research should continue to study different aspects on 
interpersonal functioning to establish the exact factors that can contribute or 
lead to a reduction in the above difficulties. Learning about specific aspects of 
interpersonal functioning and their impact on depressive symptoms could help 
clinicians set specific goals when planning an intervention. 
 The current review has indicated that CBASP intervention tends to 
improve the aspects of interpersonal functioning which are targeted by 
CBASP techniques while also reducing depressive symptoms. Somewhat 
surprisingly, the literature search revealed that the vast majority of CBASP 
studies did not include measures of interpersonal functioning. Due to the small 
amount of studies included in this review and a number of methodological 
differences between them, more research in this area is necessary to be able 
to interpret the findings with confidence. It would be useful if future studies 
focused more on the specific mechanisms of change involved in CBASP 
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which would hopefully provide us with insight into the treatment of depression 
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Background. McCullough's theory of persistent depression (2000) posits that 
childhood trauma leads to an impairment in the area of cognitive-emotional 
functioning, which causes difficulties in the interpersonal functioning, which 
then can cause depression. However, only a few studies to date have sought 
to establish the evidence for this theoretical model.  
Methods. Thirty-two patients completed and returned a questionnaire pack 
assessing childhood trauma, pre-operational thinking, reflective functioning, 
interpersonal difficulties and depression. A series of multiple regression 
analyses were used to assess the results. 
Results. No association was found between childhood adversity and the 
severity of depression. Childhood adversity, pre-operational thinking and 
interpersonal difficulties did not predict the severity of depressive symptoms. 
Furthermore, no association was found between childhood adversity and 
interpersonal functioning, or between interpersonal functioning and 
depression. The relationship remained not significant even when a subscale 
of the Inventory of Interpersonal Problems was used instead of the full scale, 
which captures a hostile submissive interpersonal style associated with 
depression. 
Limitations. It is possible that a relatively modest sample size might not have 
been sufficient to detect predicted effects. Furthermore, the responses on the 
questionnaires might not have been representative of the clinical population 
and could have been affected by social desirability bias.  
Conclusions. The results from this study were not in line with the previous 
research and did not provide further evidence for the relationships between 
the studied constructs. However, due to the limitations of the study, the 
findings should be interpreted with caution. Future studies ought to ensure 
that the samples are of sufficient size and that the participants are either at 
the pre-treatment stage when completing the questionnaires, or that the stage 
of therapy is controlled for.  
Key words: chronic depression; persistent depression; childhood trauma; 





4.2.1. Persistent depression  
 Persistent depressive disorder (PDD) (American Psychiatric 
Association, 2013) has been defined in DSM-V as depressed mood which 
continues to last, for more days than not, for at least 2 years, and is 
accompanied by two additional symptoms from the suggested list (see 
Appendix B). This often disabling and challenging mental health condition 
affects approximately 2–5% of the UK population (National Institute for Clinical 
Excellence, 2009). It has been established that about 30% of depressed 
individuals and 47% of the population accessing mental health services are 
affected by chronic forms of depression (Arnow & Constantino, 2003; Gilmer 
et al., 2005; Satyanarayana et al., 2009, Torpey & Klein, 2008).  
 Chronic depression (CD) is often associated with an early age of onset 
(Berndt et al., 2000), higher incidents of trauma (Klein & Santiago, 2003), and 
poorer social functioning (Ley et al., 2011; Wittchen et al., 2011). A study by 
Negele and colleagues (2015) found that 75.6% of chronically depressed 
patients had a history of childhood trauma. Furthermore, patients who have 
been diagnosed with persistent depression (PD) have been found to engage 
in a higher use of health services, suffer from more episodes of illness, spend 
more time in hospital, report higher rates of self-harm, and have poorer socio-
economic status (Arnow & Constantino, 2003; Howland, 1993; Torpey & Klein, 
2008). Study by McMahon et al. (2012) demonstrated that an average 
healthcare cost associated with chronic depression over the period of 3 
months was £523 as compared to £460 spent on a patient with recurrent 
depression.  Given the evidence indicating the high level of global burden 
associated with PDD, the research exploring theories of chronic depression is 
highly desirable. Advancing our understanding of psychological mechanisms 
which contribute to and maintain depressive symptoms is likely to lead to 
more refined and efficacious interventions, which in turn could reduce the risk 
of relapse. Surprisingly, despite more than 500 randomised trials focusing on 
the effects of psychotherapy on depression in the adult population, only 16 of 
the trials included in the meta-analysis by Cuijpers et al. (2010) were studies 
investigating psychological therapies for PDD.  
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4.2.2. Cognitive Behavioural Analysis System of Psychotherapy  
 4.2.2.1. Focus of Cognitive Behavioural Analysis System of 
Psychotherapy  
 Cognitive Behavioural Analysis System of Psychotherapy (CBASP) has 
been developed specifically to treat adults affected by PDD (McCullough, 
2000; 2001; 2002; 2006). CBASP can be seen as primarily a behavioural 
therapy in which interpersonal behaviours and their consequences are the 
main focus. Using a number of therapeutic tools, CBASP therapists help 
patients to reflect on the interpersonal consequences of their habitual, and 
often maladaptive, interpersonal behaviours. Once the connection between 
the problematic interpersonal behaviours and their consequences is 
established, the individual is encouraged to identify alternative behaviours, 
which are likely to lead to improved interpersonal 'connectedness'. Such 
interpersonally focused, goal-directed problem solving is aimed at helping the 
individual to navigate social situations, and as a consequence, experience a 
novel set of reinforcements occurring in the person's the environment (Swan 
& Hull, 2007; Swan et al., 2014). 
 
 4.2.2.2. Theoretical underpinnings 
 The conceptual and clinical framework of CBASP has its roots in the 
theory of cognitive development (Piaget, 1926), interpersonal theory (Kiesler, 
1983), behavioural theory (Skinner, 1953; 1969), and social learning theory 
(Bandura 1977a, 1977b). The theoretical model CBASP is based on states 
that the early onset PDD is a consequence of an impairment in cognitive-
emotional development and interpersonal functioning, which can be explained 
























Figure 1. CBASP model  
 
 According to McCullough (2003), adverse childhood events such as 
trauma prevent a young person from developing an ability to think at the 
operational level, which is characterised by logical reasoning and flexibility of 
thought (Piaget, 1926) when interacting with others. The inability to engage in 
the operational way of thinking limits the person's understanding of often 
nuanced, interpersonal dynamics. According to McCullough, even adult 
individuals who suffered stressful life events later in life can revert to 
functioning at the pre-operational levels. Functioning at the pre-operational 
levels does not allow the individual to notice the connections between their 
behaviours and the emotional as well as interpersonal aspects of their lives 
which, in turn, is thought to lead to PDD.   
 
4.2.2.3. Empirical evidence supporting the relationships within the CBASP 
model 
        A number of previous studies provided empirical evidence for the 
relationships between different variables present in the CBASP model.  
       
Childhood trauma and depressive symptoms 
 Childhood trauma has been linked to the onset, symptom severity and 
the course of depression (Gibb et al., 2007). In the majority of reported cases, 
the first episode of PDD is characterised by early onset i.e. it begins before a 
person turns 21 years old (Barbui et al., 2006; Cassano et al., 1992; Klein et 
al., 1999), and is often associated with childhood trauma (Lizardi et al., 1995; 


















(2003) has indicated that a genetic vulnerability can be associated with the 
depressive symptomatology only if the person experienced trauma in earlier 
life. 
 
Childhood trauma, cognitive-emotional development and depressive 
symptoms 
 According to McCullough, a chronically depressed individual has not 
developed operational ways of thinking in the interpersonal domain as a result 
of childhood trauma which can affect the person's ability to empathise with 
others. Operational and formal operational ways of thinking are characterised, 
among other things, by logic, ability to view things from another individual's 
perspective, metacognition, and abstract thought (Piaget, 1926). In more 
recent literature, the ability to reflect upon one's state of mind and feelings is 
often referred to as mentalisation (Fonagy, 1989) or reflective functioning 
(Fonagy et al., 1998). Two specific impairments have been associated with 
reflective functioning; hypomentalising and hypermentalising (Fonagy et al., 
2016). Hypomentalising, which has been previously linked to depression 
(Lemma et al., 2011; Luyten & Fonagy, 2013) is an inability to generate 
complex models of one's own mind and that of others. Hypermentalising, on 
the other hand, occurs when a person develops mentalistic representations of 
one's own or other actions without sufficient evidence.  
  Importantly, the research findings in this area are largely inconclusive. 
A study carried out by Vander et al. (2010) revealed that individuals who have 
been diagnosed with early-onset PDD have demonstrated significantly lower 
levels of formal reasoning as measured by the Arlin Test of Formal Reasoning 
(Arlin, 1984) when compared to non-depressed participants. A number of 
studies have also shown lower levels of reflective functioning in depressed 
individuals as compared to non-clinical samples (Fischer-Kern et al., 2008; 
Fischer-Kern et al., 2013). Furthermore, the research has found that early 
trauma correlated with the impaired development of mentalisation abilities 
(Allen et al., 2012), and childhood adversity predicted low levels of reflective 
functioning (Chiesa & Fonagy, 2014). A study by Ensink and colleagues 
(2016) found that children's capacity to mentalise partially mediated the 
relationship between child sexual abuse and depressive symptoms. In 
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contrast, a study by Taubner et al. (2011) found no difference in reflective 
functioning between chronically depressed patients receiving psychoanalytic 
treatment and healthy controls. Similarly, a study by Buckley (2017) which 
explored the relationship between reflective functioning and depression 
established that individuals with PD were no different in their ability to 
mentalise when compared to their therapists. The same study found that 
patient's level of mentalisation had no impact on depressive symptoms. The 
studies exploring theory of mind abilities (i.e. the ability to attribute mental 
states in self and others) in depressed samples have also produced mixed 
results (Mattern et al., 2015; Wilbertz et al., 2010; Zobel et al., 2010). 
  
Childhood trauma, cognitive-emotional development, interpersonal difficulties 
and depressive symptoms 
 Previous studies have established that trauma has a negative impact 
not only on the capacity to mentalise but also on interpersonal functioning. 
There is an abundance of research indicating that childhood abuse can lead 
to difficulties with developing secure attachments and healthy relationships in 
later life (Briere & Elliott, 2003; Liem & Boudewyn, 1999). The aforementioned 
study by Shipman et al. (2000) demonstrated that sexually abused girls had 
difficulties with understanding and regulating their emotions, expected less 
emotional support from others and reported more interpersonal problems than 
their non-abused peers. Wilson and Scarpa (2015) found that interpersonal 
difficulties related to hostility, emotional reactivity, inability to collaborate, and 
isolation, mediated the relationship between childhood sexual abuse and 
depressive symptoms. Leader and Klein (1996) found an overall impairment in 
social functioning in PDD. Importantly, a meta-analysis by Renner et al. 
(2014) established that improvements within the area of social functioning 
were associated with improvements in depressive symptoms. Learning to 
navigate challenging interpersonal situations through CBASP techniques 
predicted patient's improvement of depressive symptoms (Klein et al., 2011; 
Santiago et al., 2005). 
 It is worth noting that according to McCullough (2000) patients 
diagnosed with PDD exhibit a socially avoidant/hostile-submissive 
interpersonal style which limits their opportunities to experience rewarding 
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interactions. Such view is in line with a meta-analysis by Bird and colleagues 
(2018) who also found that individuals with PDD tend to show higher levels of 
hostile submissive interpersonal style than those with a diagnosis of MDD. 
Subgroup analyses revealed large effect sizes for hostile-submissiveness 
among chronically depressed patients (d=0.93). 
 
4.2.3. Rationale and aims 
 Despite a significant socio-economic burden associated with PDD, this 
mental health condition is not very well understood. Research findings 
regarding the efficacy of psychotherapies for PDD are relatively modest 
(Constantino et al., 2008; Cuijpers et al., 2010; Spijker et al., 2013; Stimpson 
et al., 2002). Despite a limited evidence base CBASP has been 
recommended as the first line of treatment for PDD in the Matrix (2015) and in 
the most recent NICE guidelines (National Institute for Clinical Excellence, 
2017) which are still at the second consultation period (more specifically, 
NICE recommended CBASP or CBT in combination with antidepressant 
medication). The Matrix guidelines used Keller’s et al. (2000) randomised 
controlled trial (RCT) to support its recommendation and graded the quality of 
this evidence as being in B category (based on the fact that it was a large 
RCT providing support for effectiveness of CBASP). The NICE guidelines 
reviewed a number of RCT’s exploring the effectiveness of CBASP and rated 
the quality of the evidence as ranging from very low to low in the majority of 
cases. Importantly, as the NICE guidelines pointed out, the quality of evidence 
was similar across all the studies exploring the effectiveness of psychological 
interventions on chronic depression not just the research exploring benefits of 
CBASP.  
 Given the above recommendations, it is important that professionals 
who work therapeutically with patients affected by PD are trained in delivering 
CBASP intervention. The NICE guidelines argue that due to a limited number 
of therapies which have been shown to be effective for people affected by PD, 
it is likely that the potential costs associated with training health professionals 
in CBASP will be balanced by the improved treatment outcome for this 
population and reduced costs of healthcare provision. Importantly, in order to 
be able to deliver therapy in a skilled and efficient manner, the therapist needs 
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to have a solid understanding of the aetiology of the difficulties and, perhaps, 
even more importantly of the mechanisms that maintain the difficulties. While 
the extensive research demonstrated a strong link between childhood trauma 
and mental health difficulties later in life, the specific mechanisms mediating 
the relationships between trauma and PDD are unclear. For example, the 
empirical support provided by the previous research for the association 
between pre-operational functioning and the other three variables in the 
model, has been inconclusive. An improved understanding of the aetiology of 
PDD and its maintenance factors is likely to lead to the development of more 
effective and better tailored treatments. The knowledge of specific 
mechanisms contributing to PDD could help therapists to plan interventions 
which specifically address these processes.  A better understanding of PDD 
could also help health services to develop research-informed strategies for 
early intervention and prevention programmes. Given the strong theoretical 
foundations for McCullough’s model of chronic depression and empirical 
findings exploring the relationships between the concepts included in the 
model, it seems like the next step is to establish the evidence for the model as 
a whole. To the author's knowledge there have been no studies testing the 
overall CBASP model in one study as of yet. Furthermore, the studies 
exploring particular concepts addressed by the model rarely focused on 
patients affected specifically by PDD.  
              The proposed study will seek to expand on empirical evidence 
supporting the model proposed by McCullough (2000; 2006). The CBASP 
theory will be explored using multiple regression analysis which will allow the 
researcher to establish associations between the concepts included the 
model.  
 
4.2.4. Research questions 
Q1: Is there a relationship between childhood trauma, pre-operational 
thinking, interpersonal difficulties and depressive symptoms in individuals with 
PD? 
 
Q2: Is childhood trauma associated with the development of PD? 
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Q3: Is childhood trauma associated with the difficulties with operational 
thinking? 
 
Q4: Is childhood trauma associated with the development of interpersonal 
difficulties? 
 




 A cross-sectional design was used to address the aims of the 
research. This type of design has a number of advantages, as it is 
inexpensive to carry out and it can be done in a relatively short period of time 
as the data is gathered only at one point in time. It can also explore a number 
of variables at any give time. The researcher presented the study proposal to 
the group of experts by experience via online forums. The feedback was 
overwhelmingly positive with regards to the aim and design of the study, and 
no changes were made as a result of it. 
 
4.3.2. Participants and sample size 
 Patients were invited to the study if they were above 18 years old; met 
the DSM-V criteria for PDD; were fluent in English; and were able to provide 
an informed consent. Patients were excluded if they suffered from psychosis 
or were unable to provide an informed consent at the time. Clinicians from 
fourteen different teams which were part of the local NHS Board were also 
introduced to the study. The teams included Primary Care Mental Health 
Teams, Psychological Therapies Services, Community Mental Health Teams 
and Older Adults Teams. Ninety-two clinicians were introduced to the study by 
the main researcher during pre-arranged meetings.  
 The primary objective of this study was to gather rich data that would 
allow the researcher to better understand the theoretical model behind 
CBASP. Power calculation for a multiple regression analysis with three 
predictors was carried out by the G*Power programme version 3.9.1.2. (Faul 
et al., 2009) to determine a sufficient sample size using an alpha of 0.05, a 
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power of 0.95, and a large effect size (f2 = 0.35). Based on the 
aforementioned assumptions, the desired sample size was 33. 
 
4.3.3. Measures 
Five questionnaires were used to collect data. It is worth noting that the 
choice of the measures suitable to use in this study was limited due to the 
cost associated with well-established measures which have been used in the 
past studies on chronic depression e.g. the Beck’s Depression Inventory (BDI, 
Beck et al., 1996)  or the Childhood Trauma Questionnaire (CTQ, Bernstein et 
al., 1998). 
 
Child Abuse and Trauma Scale (CATS; Sanders & Becker-Lausen, 1995) 
 In order to assess early adverse childhood experience the CATS was 
used. The CATS is a 38-item self-report measure of childhood abuse that 
focuses on several components of traumatic experiences. Factor analysis on 
the CATS produced three distinct subscales such as sexual abuse; 
punishment; and negative home environment/neglect. The CATS was shown 
to have good internal consistency (α = .63–.90) (Kent & Waller, 1998), strong 
test-retest reliability (r= 0.89), and a reasonable convergent validity (r= 0.29) 
(Sanders & Becker-Lausen, 1995).   
 
Luebeck Questionnaire for Recording Preoperational Thinking (LQPT, Kuhnen 
et al., 2011) 
 The LQPT is a self-report questionnaire assessing pre-operational 
thinking in chronically depressed adults. It consists of 22 scenarios which 
illustrate a number of potentially difficult interpersonal situations. Different 
aspects of preoperational thinking (snapshot perspective, prelogical thinking, 
egocentrism, lack of perceived functionality, and lack of empathy) are 
assessed by the questionnaire.  A low total score on the measure is 
associated with a high level of preoperational thinking. The study by Kuhnen 
and colleagues using a sample consisting of 30 episodically depressed, 30 
chronically depressed, and 30 healthy volunteers demonstrated that the 
German version of LQPT has good construct validity and internal consistency 
(Cronbach’s alpha = 0.90). The study has found that the scores on the LQPT 
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were able to distinguish between chronically and episodically depressed 
patients. The study by Sargin and colleagues (2018) has demonstrated good 
validity and reliability of the Turkish version of the measure.  
 
Reflective Functioning Questionnaire (RFQ-8, Fonagy et al., 2016) 
 In order to assess the ability to think at operational levels, another 
questionnaire was used alongside the LQPT. The RFQ-8 is a self-report 
measure which assesses one’s capacity to perceive and interpret the 
intentional mental states of others. Although there are no articles known to the 
researcher exploring reliability and validity of the RFQ-8, the eight items 
included in the RFQ-8 were all part of the original RFQ with research findings 
supporting its reliability and validity (Badoud et al., 2015; Fonagy et al., 2016). 
The RFQ has been found to have very good reliability and internal 
consistency (Cronbach’s alpha 0.82) (Fonagy et al., 2016). Validation studies 
of the RFQ revealed a two-dimension model; the Certainty of Mental States 
subscale which measures hypermentalising (RFQ-c) and the Uncertainty of 
Mental States subscale which measures hypomentalising (RFQ-u). This study 
will focus specifically on the subscale measuring hypomentalising which was 
found to be associated with depression.  
 
Inventory of Interpersonal Problems (IIP-32; Horowitz et al., 2000) 
 In order to assess interpersonal difficulties, the IIP-32 was used. The 
IIP-32 measures an overall interpersonal distress and each of its 8 sub-scales 
represents a separate problematic interpersonal behaviour such as difficulties 
with being assertive, sociable, supportive, and/or involved, as well as, being 
too caring, dependent, aggressive, and open. The IIP-32 is based on a 
circumplex structure of interpersonal problems categorizing interpersonal 
problems into eight subscales, which can be arranged in two dimensions and 
define a circumplex. These two dimensions are affiliation (hostile vs. friendly) 
and dominance (domineering vs. yielding). Cronbach’s alpha (0.82) and half-
split coefficients (0.82) showed that reliability of this scale is suitable (Fath et 
al., 2013). Internal consistency estimates and inter-scale correlations were 




Patient Health Questionnaire (PHQ-9, Spitzer et al., 1999) 
 In order to assess current depressive symptoms, the PHQ was used. 
The PHQ-9 is a self-report measure that is used to assess the severity of 
depression. It is mostly based on the DSM-IV depression diagnostics criteria. 
A high score on the PHQ-9 indicates a high severity of depression. PHQ-9 
scores less than or equal to 10 had a sensitivity of 88% and a specificity of 
88% for major depression. The PHQ-9 was shown (Kroenke et al., 2001) to 
have both construct and criterion validity as well as excellent internal reliability 
(Cronbach's α of 0.89). The study by Martin et al. (2006) found the PHQ-9 to 
be reliable and valid in identifying major depression as well as recognising 
milder presentations in the general population. 
 
The authors of the questionnaires were asked for the permission to use them. 
 
Demographics & chronicity of depression 
 Participants were also asked to answer a number of closed-ended 
questions aiming to gather some basic demographic information regarding 
their age, gender, years of education, relationship status, ethnicity, and the 
length and onset of their depression. 
 
4.3.4. Ethics  
 This study was granted ethical approval by the West of Scotland 
Research Ethics Committee in 2019 (REC ref no: 18/WS/0231; see Appendix 
I). The associated NHS Research and Development Office also provided 
approval for this study (R&D ref no 2018/0315; see Appendix J). The 
participant data was kept anonymous at each stage of the research process. 
An online tool was used to generate random numbers, which were then 
assigned to participant’s data. A paper sheet linking ID number to participant 
name was kept in a locked filing cabinet and only accessible by the lead 
researcher. Data was saved in a password protected folder on an NHS and 
University of Edinburgh computer. 
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4.3.5. Procedure  
 Following the ethics approval, the researcher liaised with Clinical 
Psychologists and Psychiatrists from each of the 14 different Adult Mental 
Health Services who expressed an interest in supporting the study following 
an e-mail invitation from the researcher. The researcher then visited each of 
the team and, if possible, attended one of the team meetings and introduced 
the study to all the clinicians attending the meeting. The study was explained 
to the teams using charts and FAQ (frequently asked questions) sheets. After 
explaining the study and answering any related questions, clinicians who 
expressed an interest in the study were asked to consider individuals on their 
current caseload who met the inclusion and exclusion criteria. The clinicians 
were then invited to briefly describe the study to the suitable patients from 
their caseload, the next time they saw someone for an assessment or as part 
of treatment. If the identified patient was interested in finding more about the 
study following a brief description, the clinician was asked to then pass on to 
the patient a pre-paid envelope containing a patient information sheet, 
consent forms, and a questionnaire pack. The clinician was also asked to 
instruct the patient to carefully read the information sheet at home, and if the 
person still wished to take part in the study at that point, to complete the 
questionnaires and either send them back or hand them back to the clinician 
in the provided envelope. 
  In order to introduce the study to as many clinicians and patients as 
possible, as well as comply with the data protection policies, the researcher's 
contact with the patients was kept to a minimum. The researcher spoke 
directly to the patient about the study only if the patient had already been 
seeing the researcher for therapy, or if the patient was looking for more 
information and, either contacted the researcher or consented to be contacted 
by the researcher. The questionnaires returned by the patients were sent to 
the researcher's clinical supervisor's NHS address either by the patient or by 
the clinician who introduced the patient to the study. The researcher's clinical 
supervisor passed the questionnaires onto the researcher as they arrived. The 
researcher opened the questionnaire packs, and following the anonymisation, 
separated the consent forms from the questionnaires. The researcher typed 
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the data from the questionnaires onto the NHS and University of Edinburgh 
computer using available software. 
 For the copies of the patient's information sheet, patient's consent 
sheets, and the information sheet for the clinicians, please see Appendices I, 
J, and K respectively. 
 
4.3.6. Data analysis  
 The study aimed to test a developmental model of PD proposed by 
McCullough (2000; 2006). At the initial stages of the project, there was a plan 
to use the Structural Equation Modelling (SEM) method which is a 
combination of multiple regression and factor analysis and can be used to 
analyse structural relationships (Hoyle, 1995). Testing hypotheses using SEM 
can be helpful in understanding directional and non-directional relationships 
connecting a number of observed and latent variables (MacCallum & Austin, 
2000).  Importantly, Ding and colleagues (1995) identified numerous studies 
proposing that 100 to 150 subjects is the minimum satisfactory sample size 
when conducting SEM. Unfortunately, identification of clinicians working with 
PD who would be willing to support the study proved to be challenging, and as 
a result the sample size recruited was insufficient for SEM analysis. Given the 
relatively modest sample recruited for the study, it was decided that multiple 
regression will be the most appropriate method to use in order to explore the 
relationships between the variables that are included in the McCullough’s 
model. 
A series of multiple regression analyses were conducted using the 
SPSS, version 24.0.0.2. (2013). It was ensured that the data met the 
assumptions of normality, linearity, homoscedasticity, and absence of 
multicollinearity by producing and analysing the model fit, probability plot and 
collinearity diagnostics in the SPSS. Enter method was used to enter the data 
into the system in order to assess the contribution of each independent 
variable to the model and to establish whether this addition is significantly 
different from the predictions revealed by the other variables entered into the 
model. This type of statistical analysis allows the researcher to explain the 
relationship between one continuous dependent variable (in this study: PD) 
and two or more independent variables, also called predictors (in this study: 
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trauma, cognitive-emotional development and interpersonal functioning). 
Average imputation was employed to manage missing data due to the 25 
items not being completed across the sample (0.08% of data). The average 
value of the responses from the other participants were used to fill in the 
missing values. Importantly, due to the exploratory nature of this study, a 
number of analyses has been conducted as long as they were seen as 
relevant and novel. The decision was made to include these analyses in the 
write-up regardless of the established statistical significance of the outcomes 
in order to use this opportunity to explore any emerging patterns. 
 
4.4. Results 
4.4.1. Sample characteristics 
 Thirty-two patients completed and returned the questionnaire pack. 
Demographic and clinical characteristics of the sample are presented in 
Tables 1 and 2 below. While the most frequent age bracket for the participants 
was 40 to 49, the age range of the sample was between 21 and over 60 years 
old. Females comprised just above half of the sample. The majority of the 
sample was educated to a higher level. Just above the half of the participants 
were in employment, and none of the unemployed participants were actively 
looking for a job. Nearly half of the participants never married, with almost one 
third being divorced. All participants bar one reported to be of white ethnicity.  
  Fifty-nine percent of the participants experienced early onset of 
depression (before the age of 21) while the majority of the participants 
reported the duration of their current episode to be longer 5 years. For more 





Demographic characteristics of the study sample (N=32) 
  N (%) 
Age   
 21-29 7 (22) 
 30-39 5 (16) 
 40-49 8 (25) 
 50-59 6 (19) 
 60+ 6 (19) 
Gender   
 Male 14 (44) 
 Female 18 (56) 
Ethnicity   
 White 31 (97) 
 African 1 (3) 
Education   
 None 1 (3) 
 High School 5 (15) 
 College Degree 7 (22) 
 Bachelor’s Degree 12 (38) 
 Postgraduate Degree 7 (22) 
Employment   
 Part-Time 7 (22) 
 Full-Time 10 (31) 
 Retired 5 (16) 
 Not Employed 5 (16) 
 Unable to Work 5 (16) 
Marital Status   
 Married 7 (22) 
 Divorced 10 (31) 
 Widowed 1 (3) 
 Never Married 14 (44) 
N (number of participants) 
 
Table 2 
Clinical characteristics of the study sample (N=32)  
  N (%) 
Age of Onset   
 ≤ 11 7 (22) 
 12-17 11 (34) 
 18-20 1 (3) 
 21-29 5 (16) 
 30-39 3 (9) 
 40-49 5 (16) 
Episode Duration   
 2 years 0 (0) 
 >2 years 10 (31) 
 >5 years 22 (69) 





4.4.2. Interpersonal profile 
 The Inventory of Interpersonal Problems provided a measure of 
interpersonal profile of the sample. Figure 2 illustrates the IIP-32 scores for 















Figure 3. Interpersonal profile of the participants 
 
 
 On average, participants in the current study exhibited a tendency to be 
socially avoidant as opposed to overly expressive (hostile submissive vs 
friendly dominant*), non assertive as opposed to autocratic (submissive as 
opposed to dominant*), exploitable as opposed to competitive (friendly 
submissive as opposed to hostile dominant*), and overly nurturant as 
opposed to cold (friendly vs hostile*). 
*terminology used by McCullough/CBASP 
 
 Means and standard deviation (SD) scores of all eight IIP-32 subscales 
for the PDD sample from the current study and for a non-clinical sample from 
the Locke et al.'s (2017) study are presented in Table 3 below. The normative 
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sample in the Locke et al.’s study consisted of 361 respondents and included 
English-speaking citizens of the United States and Canada who were 
recruited from the general population using Amazon’s Mechanical Turk 
(MTurk) website (Buhrmester et al., 2015). Online statistical software MedCalc 
(2020) was used to compare means and SD's of the PDD sample from this 
study and the normative sample from the Locke et al.’s study on all eight IIP 
subscales. It was found that the PDD sample experienced more interpersonal 
difficulties across all of the subscales except one (competitive/dominant 
hostile) indicating an overall difficulty across the interpersonal circumplex. The 














Interpersonal difficulties in depressed and normative samples 
 PDD Sample  Normative Sample    
Interpersonal Profile Mean SD  Mean SD  t df 
Autocratic/Dominant 0.98 1.02  0.63 0.66  -2.729** 391 
Competitive/Dominant Hostile 0.81 1.07  0.80 0.80  -0.066 391 
Cold/Hostile 1.63 1.31  0.99 0.84  -3.915** 391 
Socially Avoidant/Hostile Submissive 2.30 1.26  1.66 1.07  -3.194** 391 
Non Assertive/Submissive 2.93 1.20  1.75 0.97  -6.461** 391 
Exploitable/Friendly Submissive 2.88 1.26  1.67 0.88  -7.163** 391 
Overly Nurturing/Friendly 2.70 1.32  1.76 0.97  -5.085** 391 
Overly Expressive/ Friendly dominant 1.56 1.34  0.77 0.74  -5.327** 391 
         











4.4.3. Primary analysis 
 4.4.3.1. Descriptive statistics 
 Table 4 illustrates means and standard deviations of each of the 
outcome measures used in the primary analysis.  
Table 4  
Descriptive statistics for key variables (N=32) 
Variable Mean SD 
Depression 16.03 6.07 
Childhood Trauma 53.55 27.64 
Pre-operational Thinking 14.05 4.90 
Hypomentalising 6.63 3.63 




Abbreviations: N (number of participants), SD (Standard Deviation) 
 4.4.3.2.  Correlation analysis 
 Correlation analysis was run for all of the outcome measures which 
were completed by the patients (see Table 5). The RFQ questionnaire 
consists of two subscales which needed to be calculated separately in order 
to provide meaningful data relating to the hypermentalising and 
hypomentalising aspects of reflective functioning. In the light of evidence (Bird 
et al., 2018) suggesting that patients with PDD are more likely to be hostile 
submissive (or socially avoidant) in their interpersonal style, this particular 
subscale of the IIP was included in the analysis alongside the total IIP score.  
 Firstly, two subscales of the RFQ scale were found to be negatively 
correlated suggesting a negative association between hypomentalising (RQF-
u) and hypermentalising (RFQ-c), which is not surprising given that these two 
impairments can be seen as opposite to each other. Unsurprisingly, a positive 
moderate association was found between the full IIP scale and the hostile-
submissive subscale. Importantly, none of the other associations were found 
to be statistically significant. It is worth noting, however, that a moderate 
positive association between the outcomes on the RFQ-u and LQPT nearly 
reached statistical significance (p < .06) which might be indicative of these two 
subscales measuring similar impairments. A positive association between the 
outcomes on the LQPT and IIP also nearly reached statistical significance (p 
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< .08) indicating that that the association between pre-operational thinking and 























                  




Table 5  
Correlations of key variables (N = 32) 
Variable 1 2 3 4 5 6 7 
        
1. Childhood Trauma -       
2. Hypomentalising -.233 -      
3. Hypermentalising -.064 -.470* -     
4. Pre-operational Thinking -.040 -.336 0.348 -    
5. Interpersonal Difficulties .073 -.020 -0.74 -0.310 -   
6. Hostile-Submissive   
    Interpersonal Style  
 
.235 -.050 .230 -0.183 .464** -  
7. Depression .204 .110 -.074 -.258 .254 .190 - 
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 4.4.3.3. Model 1. Multiple regression using the outcomes on CAT, 
LQPT, IIP as predictors and the outcome on PHQ as a dependent variable 
 Multiple regression analysis was carried out to investigate whether 
childhood adversity, thinking at pre-operational levels, and interpersonal 
difficulties could significantly predict levels of depression in the PDD sample. 
The results of the first regression analysis (see Table 6) indicated that the 
model seemed to have explained only 13% of the variance and it was not a 
significant predictor of depressive symptoms (F (3,28) =1.44, p < .26). 
Childhood adversity, thinking at pre-operational levels, and/or interpersonal 




Summary of Multiple Regression Analysis (N=32) 
  B SE β t  R2 Adjusted R2 F 
          
Model 1          
 Overall Model      .04 .01 1.31 
 Childhood Trauma .05 .04 .20 1.14     
          
Model 2          
 Overall Model      .10 .04 1.68 
 Childhood Trauma .04 .04 .19 1.11     
 Pre-Operational Thinking -.31 .22 -.25 -1.42     
          
Model 3          
 Overall Model      .13 .04 1.44 
 Childhood Trauma .04 .04 .18 1.04     
 Pre-Operational Thinking -.24 .23 -.19 -1.05     
 Interpersonal Difficulties .07 .07 .18 .97     
          
Notes: Pre-operational thinking as measured by LPQT (Kuhnen et al., 2011) 
; * p < .05 ** p < .01; Abbreviations: N (number of participants) 
 
 
4.4.3.4. Model 2. Multiple regression using the outcomes on CAT, RFQ-u, IIP 
as predictors and the outcome on PHQ as a dependent variable 
 Another multiple regression analysis was performed using RFQ-u 
rather than LQPT as a measure of pre-operational thinking (see Table 7). The 
results of the regression indicated that the model using RFQ-u instead of 
LQPT also seemed to have explained only 13% of the variance and it was not 
a significant predictor of depressive symptoms (F(3,28) =1.35, p < .29). 
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Childhood adversity, thinking at pre-operational levels, and/or interpersonal 
difficulties, did not contribute significantly to the model. 
Table 7 
Summary of Multiple Regression Analysis (N=32) 
  B SE β t  R2 Adjusted R2 F 
          
Model 1          
 Overall Model      .04 .01 1.31 
 Childhood Trauma .45 .04 .20 1.14     
          
Model 2          
 Overall Model      .07 .00 1.06 
 Childhood Trauma .05 .04 .24 1.32     
 Pre-Operational Thinking .28 .31 .17 .97     
          
Model 3          
 Overall Model      .13 .03 1.35 
 Childhood Trauma .05 .04 .23 1.24     
 Pre-Operational Thinking .28 .30 .17 .92     
 Interpersonal Difficulties .09 .07 .24 1.37     
          
Notes: Pre-operational thinking as measured by RFQ-u (Fonagy et al., 2016); * p < .05 ** p < .01; N 
(number of participants) 
 
4.4.4. Secondary analysis 
  4.4.4.1. Model 3. Multiple regression using the outcomes on CAT, 
LQPT and hostile submissive/socially avoidant subscale of the IIP 
(IIPHosSub) as predictors and the outcome on PHQ as a dependent variable 
 Given the literature indicating that individuals with PDD have tendency 
to exhibit hostile submissive interpersonal style, the secondary analysis 
included the hostile submissive/socially avoidant subscale of the IIP in the 
model instead of the total IIP score. LQPT was used as a measure of 
preoperational thinking, as despite not reaching statistical significance in the 
correlation analysis, the results have suggested that there might have been a 
stronger association between the LQPT and PHQ than between the RFQ-u 
and PHQ. The regression analysis indicated that the model using IIPHosSub 
instead of the full IIP scale seemed to have explained only 11% of the 
variance (Table 8), and it was not a significant predictor of depressive 
symptoms (F(3,28) =1.11, p < .36). Childhood adversity, thinking at pre-
operational levels, and/or interpersonal difficulties, did not contribute 
significantly to the model. Using the IIP subscale did not result in a greater 
variance within the model being accounted for. 
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Table 8 
Summary of Multiple Regression Analysis (N=32) 
  B SE β t  R2 Adjusted R2 F 
          
Model 1          
 Overall Model      .04 .01 1.31 
 Childhood Trauma .05 .04 .20 1.14     
          
Model 2          
 Overall Model      .10 .04 1.67 
 Childhood Trauma .04 .04 .19 1.11     
 Pre-Operational Thinking -.31 .22 -.25 -1.42     
          
Model 3          
 Overall Model      .11 .01 1.11 
 Childhood Trauma .04 .04 .19 1.02     
 Pre-Operational Thinking -.30 .22 -.25 -1.37     
 Interpersonal Difficulties .19 .68 .05 .28     
          
Notes: IIP Hostile submissive subscale was entered into the model as one of the predictors instead of a full IIP 
scale (Horowitz et al., 2000); * p < .05 ** p < .01; N (number of participants) 
 
 
4.4.4.2. Model 4. Multiple regression using the outcomes on CAT and LQPT 
as predictors and the outcome on IIPHosSub as a dependent variable 
 Another analysis was performed to investigate whether childhood 
adversity and thinking at pre-operational levels as measured by LQPT could 
predict the levels of hostile-submissive interpersonal style in the PDD sample. 
The results of the regression indicated that the model using the outcomes on 
CAT and LQPT predicted only 4% of the variance and it was not a significant 
predictor of hostile-submissive interpersonal style (F(3,28) =0.56, p < 0.59). 
Childhood adversity and/or thinking at pre-operational levels did not predict 
the hostile-submissive interpersonal style. 
Table 9 
Summary of Multiple Regression Analysis (N=32) 
  B SE β t  R2 Adjusted R2 F 
          
Model 1          
 Overall Model      .03 .00 .95 
 Childhood Trauma .01 .01 .18 3.12     
          
Model 2          
 Overall Model      .04 -.03 .56 
 Childhood Trauma .01 .01 .17 .94     
 Pre-Operational Thinking -.26 .06 -.08 -.44     
          
Notes: Hostile submissive subscale was entered into the model as a dependent variable instead of a full IIP 
scale (Horowitz et al., 2000); * p < .05 ** p < .01; Abbreviations: N (number of participants) 
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4.5. Discussion 
4.5.1. Main findings 
 The aim of this paper was to investigate whether the model of PDD as 
proposed by McCullough is supported by empirical evidence. According to 
McCullough's theory, early experiences of childhood adversity can lead to 
depression characterised by chronic presentation. Furthermore, McCullough 
hypothesised that the link between childhood adversity and trauma can be 
explained by an impairment in the cognitive-emotional development and 
interpersonal functioning which is believed to be a consequence of traumatic 
experiences. The current study was developed to test these hypotheses using 
multiple regression analyses.  
 The findings from this study are somewhat surprising and not in line 
with previous research. Firstly, no association was established between 
childhood adversity and severity of depression. Moreover, childhood 
adversity, pre-operational thinking and interpersonal difficulties did not predict 
the severity of depressive symptoms, regardless of which measure of pre-
operational thinking was used. There was also no evidence to suggest that 
trauma leads to an impaired interpersonal functioning, even after entering 
data from the subscale of the IIP capturing hostile submissive interpersonal 
profile which has been found in the past research to be specifically associated 
with PDD. Importantly, the interpersonal circumplex for the sample from this 
study revealed that patients diagnosed with PDD have a tendency to be 
hostile submissive/socially avoidant, non assertive, exploitable and overly 
nurturant. When compared with the normative samples, patients from the 
current study were characterised by greater difficulties across the 
interpersonal circumplex except for one subscale. 
 
4.5.2. Theoretical implications 
 The findings from this study suggest the lack of associations between 
the constructs in the model developed by McCullough. However, given the 
strength of evidence supporting the links between different concepts included 
in McCullough's theory of chronic depression, it is quite likely that the lack of 
significant findings can be attributed to the flaws in the research design rather 
than the absence of meaningful relationships.  
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 In particular, the impact of childhood trauma on mental health 
difficulties in adulthood has been well supported by research. Childhood 
trauma has been specifically shown to be a risk factor for depression in later 
life both in cross-sectional and longitudinal studies (Kessler, 1997; Molnar et 
al., 2001; Tanskanen et al., 2004; Widom et al., 2007). Twenty-six studies 
included in the meta-analysis by Mandelli et al. (2015) which investigated the 
relationship between childhood trauma and depression reported small to large 
effect sizes. One of the major differences between the studies included in 
Mandelli’s review and this study is the number of participants (ranging from 66 
to 9346 per study). Therefore, it is quite likely that the relationship between 
trauma and depression has not been found in the current study due to the 
insufficient sample size to detect small or moderate effects. If the effect or the 
strength of association exists but it is subtle, the underpowered study will not 
be able to detect it. Importantly, there is balance to be struck there. While 
large values of power are desirable, the studies with excessive sample size 
are more likely to be prone to Type II error and finding effects when, in fact, 
none exist. An overpowered study can also be unethical given the effort and 
potential distress experienced by the participants and the associated waste of 
valuable resources (Suresh & Chandrashekara, 2015). However, if the 
relationships between the explored variables are indeed weaker than 
assumed in the power calculation in this study, future research should focus 
on recruiting a larger number of patients in order to increase the chance of 
identifying them. It is possible that the design of the study itself can be 
amended to allow for a greater chance of successful recruitment. This study 
involved promoting the research in multiple teams and to a large group of 
clinicians. It might be helpful in the future to establish relationships with a 
smaller group of professionals who have interest in research. 
 Furthermore, the present study found no relationship between the 
outcomes on the measures of preoperational thinking and depressive 
symptoms which is in line with a number of studies which also found no 
association between pre-operational thinking and PDD (Buckley, 2017; 
Taubner et al., 2011; Wilbertz et al., 2010). However, due to the mixed 
findings reported by the studies investigating the role of pre-operational 
thinking/reflective functioning in PD, it is difficult to draw strong conclusions 
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based on the results from the present study. Interestingly, several studies 
have found the evidence to support the mediating role of emotional regulation 
abilities in the relationship between trauma and depression (Crow et al., 2014; 
Huh et al., 2017). Difficulties with self-regulation of affect after experiencing 
adverse life events might predispose a person to develop depressive 
symptoms. Indeed, the past research has found that depressed patients show 
a tendency to adopt maladaptive strategies when regulating their emotions 
and have difficulties with effective use of adaptive strategies (Joormann & 
Stanton, 2016). There is also evidence indicating that maladaptive emotion 
regulation strategies such as suppression of emotional expression have been 
associated with worse interpersonal functioning as compared to alternative 
strategies relying on cognitive reappraisal (Gross & John, 2003). An ability to 
cope with stressful situations might be an alternative to a mediating 
mechanism of pre-operational thinking suggested by McCullough. 
 Despite the apparent lack of association between the interpersonal 
difficulties and the other variables in the model, the participants' profile on the 
interpersonal circumplex showed a tendency to adopt a hostile submissive as 
opposed to a friendly dominant interpersonal style, which was in line with the 
previous research (Bird et al., 2018). Overall, the interpersonal circumplex 
revealed submissive rather than dominant tendencies for the PDD sample 
and compared to the normative samples obtained from Locke's study, the 
participants showed an overall difficulty in the interpersonal domain. Given 
these emerging patterns, it is likely that the relationship between PDD and 
interpersonal difficulties was undetected in this study due to the small sample 
size and other methodological limitations discussed below.  
 Importantly, the findings relating to the patterns of interpersonal 
functioning among the individuals affected by PDD are clinically important as 
they not only point to the specific difficulties with interpersonal functioning that 
can be targeted in therapy but also help to predict the therapist's interpersonal 
response towards the patient. A patient behaving in a hostile manner is likely 
to evoke feelings of hostility in his/her therapist, and similarly, a patient who is 
being submissive, is likely to invite dominance from his/her therapist (Horowitz 
et al., 1997; Kiesler, 1983). McCullough (2000) recommends that the therapist 
understands his/her patient’s interpersonal style early in the treatment to be 
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able to adopt a friendly interpersonal style despite being pulled towards 
hostility and dominance. It would be useful to investigate interpersonal styles 
of different clinical populations as it is highly likely that an awareness of 
patients' interpersonal styles can be clinically beneficial with different 
presentations. 
  While the interpersonal profile of the sample revealed the difficulties in 
the interpersonal domain, no association was found between interpersonal 
difficulties and trauma. It is possible that interpersonal difficulties 
demonstrated in this study can be explained by other factors than trauma. For 
example, chronically depressed individuals who do not report childhood 
trauma might struggle in the interpersonal domain due to the reduced 
motivation to socialise and the lack of confidence associated with their 
depression. Importantly, in the majority of studies linking depressive 
symptoms to interpersonal difficulties, causal connections are not clear due to 
the cross-sectional designs (Leader & Klein, 1996). 
 Finally, it is possible that McCullough’s model of chronic depression is 
not accurate. If the evidence base for the model lacks strength, this has 
implications on the therapeutic intervention which is based on that model. 
Such inconsistent results affect the degree of certainty with which we can 
make predictions about causes of depression and the maintaining factors 
hypothesised by the model. If McCullough’s theoretical model is incorrect, the 
evidence indicating the effectiveness of CBASP intervention can be 
somewhat puzzling. Again, it is extremely important that researchers focus on 
the actual mechanisms and components of the therapy that lead to clinical 
changes such as specific CBASP techniques or non-specific factors such as 
therapeutic relationship. It is necessary to continue building on the past 
studies in order to increase our confidence in empirical support for the model 
while exploring other possible explanations.   
It is also worth pointing out that while McCullough's model primarily 
focuses on the early onset PDD, in order to maximise the number of 
participants taking part, the late onset depression was not an exclusion 
criterion. In fact, 41% of the sample reported experiencing the first episode 
later in life. It could be useful to focus specifically on the individuals reporting 
early onset of PDD in the future studies. 
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4.5.3. Limitations and avenues for further research 
 A number of further limitations have been identified that might have 
contributed to the present findings. Firstly, the outcome measures used, 
especially the PHQ-9, might not have been the most suitable to capture 
different levels of severity of PDD, since it was designed as a short screening 
for MDD. In fact, it has been established in the past (Wittkampf, 2009) that the 
correlation between the PHQ-9 and HAM-D, the clinician administered 
measure of severity of depression, is relatively low (r=0.52, p<0.01). The 
authors of that study have concluded that while the PHQ-9 might be a good 
screening tool, it should be accompanied by other measures when assessing 
the severity of depression. Interestingly, the majority of the previous studies 
which found the relationship between depressive symptoms and interpersonal 
functioning or trauma used the BDI (Beck et al., 1996), the HAM-D (Hamilton, 
1960), or both. Unfortunately, due to the nature of the project and restricted 
budget it was not viable to use measures such as the BDI. The BDI-II is a 21-
item self-report inventory measuring the severity of depression in adolescents 
and adults and was revised in 1996 to be more consistent with DSM-IV 
criteria for depression. A higher number of items on the BDI as compared to 
the PHQ and good psychometric properties of the questionnaire, would likely 
allow for a greater depth and precision of the assessment which would, in 
turn, lead to the increased validity of the results. Similarly, it would have been 
helpful to use HAM-D which is a clinician administered questionnaire for 
depression to gain another perspective and perhaps produce more insightful 
findings.  
Moreover, both measures of pre-operational thinking used in the 
present study (the RFQ-8 and LPQT) are relatively new and not well-
established. To the author's knowledge there have been no articles 
investigating reliability and validity of these two measures with English 
speaking samples. The items included in the RFQ-8 have only been validated 
as part of the research validating the original, longer version of the 
questionnaire, and the LQPT has been validated with German and Turkish 
speaking samples only. The future studies should focus on validating these 
questionnaires with English speaking sample. It might have also been useful 
to use the CTQ measure (Bernstein et al., 1998) instead of the CATS which 
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has been widely used in the past when exploring trauma and mental health 
difficulties (Spinhoven et al., 2014). The CTQ has good psychometric 
properties and has been validated with a number of different populations. In 
comparison to the CATS measure which has three subscales, the CTQ has 
five subscales (emotional abuse, physical abuse, sexual abuse, emotional 
neglect and physical neglect), and as a result, captures broader dimension of 
childhood maltreatment. 
 Another major limitation which might have affected the results is the 
fact that in order to maximise the likelihood of successful recruitment, 
participants were included to the study regardless of the stage of therapy they 
were at. In fact, as a way of ensuring patient’s suitability for the study and to 
minimise potential distress associated with filling out the questionnaires, the 
clinicians may have been more likely to recruit potential participants in the 
later stages of therapy. A patient who was referred with severe symptoms of 
depression, might have scored much lower on the PHQ in the middle phase of 
the therapy as opposed to the initial phase. Similarly, the difficulties in the 
interpersonal functioning might have reduced by the time a patient was asked 
to take part in the research. Importantly, the symptom change can occur 
within first several sessions in the CBASP therapy (Schramm et al., 2015). As 
a result, the link between the independent variable i.e. the experiences of 
trauma and the dependent variables could have been weakened for these 
patients as despite their experience of childhood adversity, their mental health 
symptoms might have improved by the time they were asked to fill out the 
questionnaires. It is even possible that some patients have returned the 
questionnaires after the therapy ended, or when their motivation levels have 
improved as a result of the reduction in their symptoms. It would have been 
useful to confirm the diagnosis of PDD with a patient just prior to filling out the 
questionnaires by the patient.  
Furthermore, due to the fact that the clinician who would have 
introduced the patient to the study was also acting as their therapist, the 
outcomes reported might have been somewhat inaccurate due to the social 
desirability bias. Research findings have shown that reporting symptoms of 
depression by a person affected by this condition is indeed affected by this 
phenomenon (Fastame & Penna, 2012). Ideally, this study should have been 
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introduced by an independent researcher to the patients who were pre-
treatment. 
 Finally, the cross-sectional nature of the study and its correlational 
design do not allow the researcher to make conclusions about causal 
relationships between the constructs. It would be useful if the future studies 
employed longitudinal designs which could offer additional insights into the 
nature of associations between the investigated constructs. Future 
longitudinal studies could also explore a potential bidirectional relationship 
between interpersonal difficulties and depression. 
 
4.5.4. Conclusions & implications for future practice 
 The present study did not provide support for the hypothesised 
relationships between the constructs in McCullough's model of chronic 
depression. However, taking previous research findings into account, it is 
likely that these relationships do, in fact, exist but are perhaps weaker and 
more nuanced than suggested by McCullough. In order to increase validity 
and reliability of future findings, researchers should address a number of 
design flaws present in this study when developing new studies. If the 
relationships explored in this research are indeed weaker than predicted, it 
will be useful to increase the sample size to make sure that the future studies 
have enough power. A larger sample size would also allow the researchers to 
make meaningful comparisons between the individuals reporting early onset 
depression with those who have experienced depression later in life. 
Furthermore, it would be helpful to use measures such as the BDI which 
might be more valid when assessing the severity of depressive symptoms as 
compared to their free of charge counterparts such as the PHQ-9. It might 
also be crucial to ensure that the patients taking part in the future studies 
have not yet started therapy and are meeting the criteria for PD at the time of 
completing the questionnaires. Finally, the longitudinal designs, while more 
difficult and expensive to implement, can offer invaluable insight into causal 
relationships between studied concepts.  
Given the ever-increasing prevalence, chronicity, negative impact on a 
person's life, and the global burden associated with PDD, it is essential to 
continue research into this area if we wish to gain a better understanding of 
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this debilitating condition and recommended treatments. Importantly, the 
above study draws attention to the model that was developed to treat a 
condition that is both complex and often treatment resistant. Given the current 
clinical guidelines and a limited number of treatments which were shown to be 
effective with the PD population, studies into CBASP will hopefully encourage 
clinicians to seek training in this area, including developing skills in CBASP 
delivery. Furthermore, a better understanding of the model of PD is likely to 
allow healthcare professionals to further tailor the therapeutic interventions 
they offer to meet the patient’s needs, and might aid the development of 
effective preventative interventions that might decrease the chance of PDD 
developing in the first place. The lack of statistically significant findings 
demonstrated in this study, at the very least, encourages us to revisit some of 
the mechanisms that have been linked to the development of depression in 
the past. While some of these associations have been supported by past 
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Appendix B. DSM-V Diagnostic criteria for Major Depressive Disorder 
The DSM-5 outlines the following criterion to make a diagnosis of depression. The 
individual must be experiencing five or more symptoms during the same 2-week 
period and at least one of the symptoms should be either (1) depressed mood or (2) 
loss of interest or pleasure. 
1. Depressed mood most of the day, nearly every day. 
2. Markedly diminished interest or pleasure in all, or almost all, activities most of 
the day, nearly every day. 
3. Significant weight loss when not dieting or weight gain, or decrease or 
increase in appetite nearly every day. 
4. A slowing down of thought and a reduction of physical movement (observable 
by others, not merely subjective feelings of restlessness or being slowed 
down). 
5. Fatigue or loss of energy nearly every day. 
6. Feelings of worthlessness or excessive or inappropriate guilt nearly every 
day. 
7. Diminished ability to think or concentrate, or indecisiveness, nearly every day. 
8. Recurrent thoughts of death, recurrent suicidal ideation without a specific 
plan, or a suicide attempt or a specific plan for committing suicide. 
To receive a diagnosis of depression, these symptoms must cause the individual 
clinically significant distress or impairment in social, occupational, or other important 
areas of functioning. The symptoms must also not be a result of substance abuse or 





























Appendix C. DSM-V Diagnostic criteria for Persistent Depressive Disorder 
 
Persistent Depressive Disorder (Dysthymia)  
 
This disorder represents a consolidation of DSM-IV-defined chronic major depressive 
disorder and dysthymic disorder. 
 
A. Depressed mood for most of the day, for more days than not, as indicated by 
either subjective account or observation by others, for at least 2 years. 
Note: In children and adolescents, mood can be irritable and duration must be at 
least 1 year. 
 
B. Presence, while depressed, of two (or more) of the following: 
1. Poor appetite or overeating. 
2. Insomnia or hypersomnia. 
3. Low energy or fatigue. 
4. Low self-esteem. 
5. Poor concentration or difficulty making decisions. 
6. Feelings of hopelessness. 
 
C. During the 2-year period (1 year for children or adolescents) of the disturbance, 
the individual has never been without the symptoms in Criteria A and B for more than 
2 months at a time. 
D. Criteria for a major depressive disorder may be continuously present for 2 years. 
E. There has never been a manic episode or a hypomanic episode, and criteria have 
never been met for cyclothymic disorder. 
F. The disturbance is not better explained by a persistent schizoaffective disorder, 
schizophrenia, delusional disorder, or other specified or unspecified schizophrenia 
spectrum and other psychotic disorder. 
G. The symptoms are not attributable to the physiological effects of a substance 
(e.g., a drug of abuse, a medication) or another medical condition (e.g., 
hypothyroidism). 
H. The symptoms cause clinically significant distress or impairment in social, 











































































Appendix F. Details of the main measures used by the included studies 
 
Measure Validity & Reliability 
BDI-II, Beck's Depression Inventory (Beck, Steer, & Brown, 1996)  
The BDI-II is a widely used 21-item self-report inventory measuring 
the severity of depression in adolescents and adults. The BDI-II was 
revised in 1996 to be more consistent with DSM-IV criteria for 
depression 
Good internal consistency (from 0.83-0.96) and the retest reliability 
(from 0.73 to 0.96); good criterion-based validity showed good 
sensitivity and specificity for detecting depression (Wang & 
Gorenstein, 2013). 
 
GAF, Global Assessment of Functioning (American Psychiatric 
Association, 1987)  
GAF covers the range from positive mental health to severe 
psychopathology and is an overall measure of how patients are doing, 
administered by a clinician 
Reliability studies show that the extreme 20% of raters can account 
for more than 50% of the spread of scores and that there can be 
deviations of 20 points or more; overall reliability can be good, but it 
is lower in the routine clinical setting (Vatnaland, Vatnaland , Friis, 
& Opjordsmoen, 2007); poor discriminant  validity (Grootenboer et 
al., 2012) 
HAM-D/HRSD (Hamilton, 1960) Hamilton Depression Rating Scale 
The HDRS/HAM-D is clinician-administered outcome measure of 
depression. 
Adequate internal reliability; some items poor contributors to the 
measurement of depression severity while others have poor interrater 
and retest reliability; content validity is poor; convergent validity and 
discriminant validity are adequate (Bagby, Ryder, Shuller, & 
Marshall, 2004). 
IDS-R the Inventory of Depressive Symptomatology, Self-Report  
(Rush, Gullion, Basoo, Jarrett, & Trivedi, 1996). 
IDS-R is an outcome measure of depression 
 
Internal consistency ranged from 0.92 to 0.94 for the total sample 
and from 0.76 to 0.82 for those with current depression; the inter-
rater reliability 0.96; good concurrent validity with HAM-D (Rush et 
al., 1996). 
IIP, Inventory of Interpersonal Problems IIP-64/IIP-32 (Horowitz, 
Alden, Wiggins, & Pincus, 2000)  
IIP scale designed to assess interpersonal problems in adult people. 
The main problems contain: sociability, assertiveness, aggression, 
supportiveness, involvement, caring, openness and dependency. The 
IIP-64 is based on a circumplex structure of interpersonal problems 
For the IIP-32, the significant positive relationship between 
interpersonal problems and alexithymia indicated good convergent 
validity; Cronbach’s alpha (0.82) and half-split coefficients (0.82) 
showed that the reliability of this scale is also suitable (Fath, 
Azzadfallah, Rasoolzadeh, & Rahimi, 2013) 
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(Horowitz, Dryer, & Krasnoperova, 1997) categorizing interpersonal 
problems into eight subscales, which can be arranged in two 
dimensions and define a circumplex. These two dimensions are 
affiliation (cold/hostile vs. warm/friendly) and dominance 
(domineering vs. yielding). 
 
For the IIP-64, the properties have been evaluated in both clinical 
and non-clinical groups and IIP-64 is considered to have acceptable 
to good reliability and validity (Horowitz et al., 2000) 
 
 
IMI-C Impact Message Inventory (IMI-C; Kiesler & Schmidt, 2006) 
IMI assesses a person’s interpersonal style indirectly, by asking others 
what reactions the person typically evokes in them (can be used also as 
a therapy tool to assess interpersonal pressures) 
 
Acceptable internal consistency; adequate circumplex structure; very 
good reliability (Kiesler & Schmidt, 2006) 
 
MADRS, Montgomery-Asberg Depression Rating Scale (Montgomery 
& Asberg, 1979) 
MADRS is an outcome measure for depression  
 
High inter-rater reliability of the new depression; high correlation 
with HRSD indicating its validity as a general severity estimate; 
greater sensitivity to change than that of HRSD (Montgomery & 
Asberg, 1979) 
 
PEF, Patient Evaluation Form (Brakemeier, Strunk, Normann, & 
Schramm, 2010) 
PEF has been designed to measure patients’ acceptance and feasibility 
of CBASP group psychotherapy in an inpatient setting 
PEF (n = 65) showed excellent internal 
consistency with .95 (Cronbach’s α) and good test–retest reliability 
with r = .81 (SaƄas et al., 2018). 
SAS-SR , Social Adjustment Scale - Self-Report SAS-SR (Weissman, 
1999) 
SAS-SR is a measure of social adjustment. Questions focus on social 
functioning (e.g. in relation to work, leisure, relationships, family) 
during the preceding month. 
Satisfactory internal consistency (Cronbach’s α = .74; Edwards, 
Yarvis, Mueller, Zingale, & Wagman, 1978) and convergent validity 
with measures of depression; differentiated psychiatric patients from 
a mixed-age community sample (Weissman, Prusoff, Thompson, 
Harding, & Myers, 1978) 
SASS, The Social Adaptation Self-Evaluation Scale (Bosc, Dubini, & 
Polin, 1997) 
SASS is used to evaluate different aspects of social interactions, global 
social attitude, and self-perception. It covers various areas of social 
The SASS has been validated and found to be simple 
to use, reliable and sensitive to changes in different areas of social 
functioning (Bosc et al., 1997) 
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functioning including work, spare time, family, environmental 
organisation, and coping abilities. 
 
 
SF-36, Short Form Survey (Ware & Sherbourne 1992) 
The SF-36 is a widely used 36-item self-report measure of general 
health and functioning. One of the SF-36 subscales is the Social 
Functioning subscale which measures to what extent emotional and 
health problems interfere with social activities. 
SF-36 has been adapted and translated into several languages, and its 
validity and reliability established in several countries (Gandek et al., 
1998). Social Functioning subscale was shown to have good 
construct validity (McHorney, Ware, & Raczek, 1993), high internal 
consistency, and test-retest reliability (Ruta, Abdalla, Garratt, Coutts, 
& Russell, 1994) 
 
WHOQOL-BREF World Health Organization Quality of Life 
assessment (Group, 1998)  
The WHOQOL-BREF contains two 
items from the ‘overall quality of life’, and ‘general health’ 
domains of the longer WHOQOL-100, and 24 items each 
corresponding to the 24 factors of the WHOQOL-100. The 
24 items are clustered into four further domains: physical 
health, psychological health, social relationships, and environment. 
A cross-sectional design in 23 countries across the world was used to 
assess the psychometric properties of WHOQOL-BREF and found 
sound psychometric properties on internal consistency as well as 
discriminant and construct validity (Skevington, Lotfy, & O'Connell, 
2004). Social relationships scale was shown to have high internal 
consistency (Cronbach’s α = 0.73) and adequate construct validity 























































Appendix I. Participant Information Sheet 
 
Participant Information Sheet  
The use of Structural Equation Modelling as a test of Cognitive Behavioural Analysis 
System of Psychotherapy 
 
You are being invited to take part in a research study. Before you decide 
whether or not to take part, it is important for you to understand why the 
research is being done and what it will involve.  Please take time to read the 
following information carefully. Talk to others about the study if you wish.  
Contact us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
Our understanding of depression and its treatment has broadened over the past 
several decades. Cognitive Behavioural Analysis System of Psychotherapy (CBASP) 
is a psychological therapy that has been developed to specifically address the 
difficulties of individuals affected by persistent depression. A number of previous 
studies produced some evidence for relationships between different concepts that 
are present in the model CBASP is based on. However, there is not much research 
investigating an overall model of CBASP and therefore, this study will aim to explore 
the relationships between the concepts within the model i.e. the relationships 
between adverse childhood experiences, interpersonal difficulties, cognitive-
emotional development and persistent depression.   
 
Why have I been asked to take part? 
You have been asked to take part as you have been diagnosed as having symptoms 
of persistent depression by a health professional. 
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part. If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent form.  
If you decide to take part you are still free to withdraw at any time and without giving 
a reason. Deciding not to take part or withdrawing from the study will not affect the 
healthcare that you receive, or your legal rights.  If you wish to withdraw, you would 
need to let the research team know by the end of September 2019 before the data 
analysis takes place. 
 
What will happen if I take part? 
To start will you will be asked to read and sign the consent form if you wish to take 
part in the study. You will be then asked to complete five questionnaires. The 
questionnaires will ask you about a number of experiences from your life such as the 
nature of your relationships with other people, your way of thinking about different 
things and your current symptoms of depression. One of the questionnaires will also 
ask you about adverse and possibly upsetting experiences from your childhood. 
Finally, you will be asked about your demographic information including age, gender, 
the length and onset of your depression etc. 
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It should take you no more than 30 minutes to answer all the questionnaires and you 
will be asked to answer them only ONCE. You will then be asked to send back the 
questionnaires and the signed consent form using the pre-paid return envelope or 
hand them back to the health professional who invited you to the study.  
 
What are the possible benefits of taking part? 
You may not get a direct benefit from taking part in this study. However, the results 
from this study might inform on the future healthcare of other patients. Testing and 
evaluating the model CBASP is based on will allow us to better understand how 
persistent depression develops. Such understanding will help us to identify risk 
factors associated with persistent depression and develop preventative interventions. 
It is also likely to lead to more refined therapeutic interventions.  
 
What are the possible disadvantages and risks of taking part? 
It is not thought that there are many disadvantages of taking part in this study. 
However, it is possible that while or after completing the questionnaires you might 
feel uncomfortable or distressed. One of the questionnaires will ask you about 
adverse and potentially upsetting experiences from your childhood, for example, 
experiences of childhood abuse and trauma. Importantly, if you notice yourself 
getting upset, please remember it is absolutely normal to feel like this when actively 
thinking about difficult experiences from the past or present. It is also O.K. to stop 
completing the questionnaires if you feel overwhelmed. Finally, in the event you need 
to speak to someone about your feelings following taking part in the study, please 
speak to the healthcare professional who first introduced you to the study. If this is 
not possible, or you were invited to take part in the study via post please speak to 
your GP about your feelings. Additionally, there are number of organisations whom 
you can contact if you are looking for further emotional support. These are: 
 
NHS24 - CALL 111 (urgent health advice out of hours) 
Samaritans CALL 116 123 or e-mail jo@samaritans.org (24hrs a day, free helpline 
providing emotional support to anyone in distress) 
Breathing Space CALL 0800 83 85 87 (6pm to 2am on weekdays, and 24 hours at the 
weekend, free helpline providing psychological counselling to anyone in distress) 
Campaign Against Living Miserably  CALL 0800 585858 (5pm to midnight, daily, helpline 
for men who are struggling with mental health) 
Open Secret CALL 01324 630 100 (confidential support for survivors of childhood 
abuse and trauma) 
 
Will my taking part in the study be kept confidential? 
All the information we collect during the course of the research will be kept 
confidential and there are strict laws which safeguard your privacy at every stage.  
 
Importantly, if your answers in the questionnaires suggest you or someone in your 
environment is at risk of harm, the study researchers will need to share this 
information with the clinician who invited you to the study or if that is not possible with 
your GP to ensure your own or someone else's safety. If you make a criminal or any 
other type of disclosure about a particular person, this information might also need to 
be shared with the clinician who invited you to the study or your GP, and local risk 
management processes might need to be followed.  
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The study researchers ask you to provide your date of birth on this form so we can 
access your medical records in order to obtain your GP's address, your own address 
and your CHI number. We need your GP's address to let them know about you 
taking part in this study. The letter to your GP is likely to include your address and 
CHI number to help to identify you correctly. If we decide to share the information you 
have provided in the questionnaires with your clinician as part of the risk 
management, we might also use your medical records to access contact details of 
the clinician who introduced you to the study.  We will inform you about our 
communication with your clinician via a letter. 
 
To ensure that the study is being run correctly, we will ask your consent for 
responsible representatives from the Sponsor and NHS Institution to access your 
medical records and data collected during the study, where it is relevant to you taking 
part in this research. The Sponsor is responsible for overall management of the study 
and providing insurance and indemnity. 
 
What if there is a problem?  
 
If you decide to withdraw from the study after returning the questionnaires to the 
research team, please use the contact e-mail above and let us know you wish to 
withdraw. If you wish to withdraw, you would need to let the research team know by 
the end of September 2019 before the data analysis takes place. 
 
In the unlikely event that something goes wrong and you are harmed during the 
research and this is due to someone‘s negligence then you may have grounds for a 
legal action for compensation against NHS Lothian but you may have to pay your 
legal costs. The normal National Health Service complaints mechanisms will still be 
available to you (if appropriate). 
 
What will happen to the results of the study? 
Once enough participants have returned the signed consent forms and the 
questionnaires, the collected data will be anonymised and analysed using a statistical 
programme. At the end of the research which is scheduled for April 2020 we will 
share the results with the clinical teams or the research team we have recruited the 
participants from. You are welcome to contact the team that invited you to the study 
to find out about the results. The research team will also aim to publish results of the 
study as a thesis and as an article in a peer-reviewed journal. You will not be 
identifiable in any published results. 
 
When you agree to take part in a research study, the anonymised information you 
provided to researchers may be provided to researchers running other research 
studies in this organisation and other organisations These organisations may be 
universities, NHS organisations or companies involved in health and social care 
research. Your information will only be used to conduct research in accordance with 
the UK Policy Framework for Health and Social Care Research. This information will 
not identify you and will not be combined with other information in a way that could 
identify you. The information will only be used for the purpose of health and social 
care research and cannot be used to contact you or affect your care. 
 
Who is organising the research and why? 
This study has been organised/sponsored by the University of Edinburgh.  
 152 
 
Who has reviewed the study? 
The study proposal has been reviewed by the research team from the University of 
Edinburgh and by a clinical supervisor within the NHS. All research in the NHS is 
looked at by an independent group of people, called a Research Ethics Committee. A 
favourable ethical opinion has been obtained from xxx REC.  NHS management 
approval has also been obtained. 
 
If you have any further questions about the study please contact Karolina 
Szpak at s1794325@sms.ed.ac.uk or Dr Timothy Bird at timothy.bird@ed.ac.uk 
 
If you would like to discuss this study with someone independent of the study 
please contact:  Helen Griffiths, Programme Director of the University of 
Edinburgh/NHS Scotland Clinical Psychology training programme 
School of Health in Social Science 
Contact no: +44 (0) 131 6503482 
E-mail: helen.griffiths@ed.ac.uk 
If you wish to make a complaint about the study please contact NHS Lothian: 
NHS Lothian Complaints Team 
2nd Floor 
Waverley Gate 
2 - 4 Waterloo Place 
Edinburgh 
EH1 3EG 
Tel: 0131 465 5708 
complaints.team@nhslothian.scot.nhs.uk. 
 
If you wish to take part in this study after reading the information sheet, please 
read and sign the consent form, and complete the attached questionnaires. 
Once you have completed all the questionnaires, please send the signed 
consent sheet and the questionnaires to the research team using the pre-paid 
return envelope. Alternatively, hand the signed consent form and the 
completed questionnaires back to the healthcare professional who invited you 
take to part in the study. 
 
You can find out more about how we use your information and our legal basis for 
doing so in our Privacy Notice at www.accord.scot.  
For further information on the use of personal data by NHS sites, please link to the 
Health Research Authority (HRA) website; https://www.hra.nhs.uk/information-about-
patients/.  
If you wish to raise a complaint on how we have handled your personal data, you can 
contact our Data Protection Officer who will investigate the matter. If you are not 
satisfied with our response or believe we are processing your personal data in a way 
that is not lawful you can complain to the Information Commissioner’s Office (ICO) at 
https://ico.org.uk/.  
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Data Protection Officer contact 
information: University of 
Edinburgh  
Data Protection Officer  
Governance and Strategic Planning  
University of Edinburgh  
Old College  
Edinburgh  
EH8 9YL  
Tel: 0131 651 4114  
dpo@ed.ac.uk  
NHS Lothian  
Data Protection Officer  
NHS Lothian  
Waverley Gate  
2-4 Waterloo Place  
Edinburgh  
EH1 3EG  















































Appendix J. Participant Consent Form 
 
CONSENT FORM 
[CBASP model study] 
 
 
 Please initial box 
 
 1. I confirm that I have read and understand the information sheet (Version 1, 
20/11/2018) for the above study and have had the opportunity to consider the 
information and ask questions. 
 
 2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected. 
 
3.  I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals from the regulatory 
authorities and from the Sponsors (NHS Lothian and the University of 
Edinburgh) or from other NHS Boards where it is relevant to my taking part in 
this research. I give permission for those individuals to have access to my 
records. 
 
4.  I agree to my anonymised data being used for future ethically 
approved studies.  
 
5. I agree to my General Practitioner being informed of my participation in this study  
 
7. I agree to take part in the above study. 
 
 
Name of Participant  
________________________   
 








Please note: Original of the Consent form (x1) to be retained in site file.  Copy of the 
Consent form (x1) to be included in patient notes.  Copy of the Consent form (x1) to 











Appendix K. Information sheet for clinicians 
 
INFORMATION SHEET FOR CLINICIANS  
The use of Structural Equation Modelling as a test of Cognitive Behavioural 
Analysis System of Psychotherapy 
 
This sheet was developed in order to address frequently asked questions by 
clinicians who are interested in finding more about the above study.  
 
WHAT DOES A CLINICIAN HAVE TO DO? 
The clinician is asked to briefly introduce the potential participant to the study and if 
the person is interested in finding out more about it, the clinician is asked to give the 
person an envelope, provided by the researcher, containing all the required 
paperwork such as a participant information sheet and consent form, as well as 
questionnaires that the person will be asked to complete if he/she decides to take 
part. 
 
WHAT ARE THE INCLUSION AND EXCLUSION CRITERIA? 
We are looking for participants who have been affected by persistent depression 
(depressed mood for at least the last 2 years and, during the last 2 years, not without 
symptoms meeting the criteria for persistent depressive disorder for more than 2 
months at a time). Please see the details of the inclusion and exclusion criteria as 
well as the DSM-V diagnostic criteria for persistent depression on page 3. 
 
WHY IS THE STUDY HELPFUL? 
The study aims to explore a theoretical model behind CBASP - a therapy for chronic 
depression (Cognitive Behavioural Analysis System of Psychotherapy). Results of 
this study are likely to increase our understanding of chronic depression and how it 
develops throughout our lifetime. Increased understanding of the model behind 
chronic depression will allow us to develop more effective therapies for this condition. 
Importantly, increased understanding of the risk factors associated with the chronic 
depression might help to prevent it altogether. 
 
WHAT WILL THE PARTICIPANT HAVE TO DO? 
The person will be given an envelope with all the paperwork that needs to be 
completed. Yellow pages, all stapled together inside the envelope, provide 
information for the person interested in the study to learn more about it before 
deciding whether to take part in it 
 White pages, also stapled together inside the envelope, are to be completed 
and sent back by the person if they decide to take part in the study. The white pages 
should take no more than 30minutes to complete. White pages include the consent 
form the person needs to read and sign, and a demographics questionnaire. They 
also include 5 additional questionnaires addressing areas such as adverse childhood 
experiences, cognitive and emotional difficulties, interpersonal difficulties and 
symptoms of depression.  
 Once the person completes all of the questionnaires and the consent 
form (i.e. all the white sheets), they will be asked to send them back in the 
same envelope they found the paperwork in. The envelope is addressed to the 
researchers who are conducting the study. 
 
WILL THE INFORMATION COLLECTED THROUGH THE QUESTIONNAIRES BE 
CONFIDENTIAL? 
 All the information collected during the course of the research will be kept 
confidential. The researchers ask the participants to provide them with their name 
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and D.O.B. on the consent form so the researchers can inform the person's GP 
about them taking part in the study. 
WHAT IF THE PARTICIPANT BECOMES UPSET? 
 The participant does not have to continue completing the questionnaires if he/she 
feels overwhelmed. If the participant feels that he/she needs to speak to someone 
about their feelings, they can speak to the healthcare professional who first 
introduced them to the study, or if this is not possible, to their GP. Additionally, details 
of organisations offering relevant emotional support are listed within the participant’s 
information sheet. 
If you have any further questions about the study please contact Karolina 
Szpak at s1794325@sms.ed.ac.uk or Dr Timothy Bird at timothy.bird@ed.ac.uk 
 
THANK YOU FOR SUPPORTING THE STUDY 
 
Inclusion criteria: 
• 18 years old or above 
• currently attending NHS Adult Mental Health Service (e.g. for treatment, 
assessment or triage) 
• depressed for at least 2 years 
• during the last 2 years participant was never without the symptoms meeting 
criteria for persistent depressive disorder for more than 2 months at a time 
• fluent in spoken and written English 
Exclusion criteria: 
• diagnosis of psychosis 
• lack of capacity to give consent 
DSM-V Diagnostic criteria for Persistent Depressive Disorder 
Persistent Depressive Disorder (Dysthymia) 300.4 (F34.1) 
 
This disorder represents a consolidation of DSM-IV-defined chronic major depressive 
disorder and dysthymic disorder. 
 
A. Depressed mood for most of the day, for more days than not, as indicated by 
either subjective account or observation by others, for at least 2 years. 
Note: In children and adolescents, mood can be irritable and duration must be at 
least 1 year. 
 
B. Presence, while depressed, of two (or more) of the following: 
1. Poor appetite or overeating. 
2. Insomnia or hypersomnia. 
3. Low energy or fatigue. 
4. Low self-esteem. 
5. Poor concentration or difficulty making decisions. 
6. Feelings of hopelessness. 
 
C. During the 2-year period (1 year for children or adolescents) of the disturbance, 
the individual has never been without the symptoms in Criteria A and B for more than 
2 months at a time. 
D. Criteria for a major depressive disorder may be continuously present for 2 years. 
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E. There has never been a manic episode or a hypomanic episode, and criteria have 
never been met for cyclothymic disorder. 
F. The disturbance is not better explained by a persistent schizoaffective disorder, 
schizophrenia, delusional disorder, or other specified or unspecified schizophrenia 
spectrum and other psychotic disorder. 
G. The symptoms are not attributable to the physiological effects of a substance 
(e.g., a drug of abuse, a medication) or another medical condition (e.g., 
hypothyroidism). 
H. The symptoms cause clinically significant distress or impairment in social, 















































Appendix L. Author guidelines for the Journal of Affective Disorders 
Description  
 
The Journal of Affective Disorders publishes papers concerned with affective 
disorders in the widest sense: depression, mania, anxiety and panic. It is 
interdisciplinary and aims to bring together different approaches for a diverse 
readership. High quality papers will be accepted dealing with any aspect of affective 
disorders, including biochemistry, pharmacology, endocrinology, genetics, statistics, 
epidemiology, psychodynamics, classification, clinical studies and studies of all types 
of treatment. 
Submission checklist  
 
You can use this list to carry out a final check of your submission before you send it 
to the journal for review. Please check the relevant section in this Guide for Authors 
for more details.  
Ensure that the following items are present: 
One author has been designated as the corresponding author with contact details: 
• E-mail address 
• Full postal address  
All necessary files have been uploaded: 
Manuscript: 
• Include keywords 
• All figures (include relevant captions) 
• All tables (including titles, description, footnotes) 
• Ensure all figure and table citations in the text match the files provided 
• Indicate clearly if color should be used for any figures in print 
Author Statement Contributors, Role of the Funding Source and Acknowledgements 
are mandatory and must be retained in the Author Statement (submission file type) 
under their respective headings. 
Graphical Abstracts / Highlights files (where applicable) 
Supplemental files (where applicable) 
Further considerations 
• Manuscript has been 'spell checked' and 'grammar checked' 
• All references mentioned in the Reference List are cited in the text, and vice versa 
• Permission has been obtained for use of copyrighted material from other sources 
(including the Internet) 
• A competing interests statement is provided, even if the authors have no competing 
interests to declare 
• Journal policies detailed in this guide have been reviewed 
• Referee suggestions and contact details provided, based on journal requirements  
For further information, visit our Support Center. 
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Ethics in publishing  
 
Please see our information pages on Ethics in publishing and Ethical guidelines for 
journal publication. 
Ethical Considerations  
 
Authors of reports on human studies, especially those involving placebo, symptom 
provocation, drug discontinuation, or patients with disorders that may impair 
decision-making capability, should consider the ethical issues related to the work 
presented and include (in the Methods and Materials section of their manuscript) 
detailed information on the informed consent process, including the method or 
methods used to assess the subject's capacity to give informed consent, and safeguards 
included in the study design for protection of human subjects. Specifically, authors 
should consider all ethical issues relevant to their research, and briefly address each of 
these in their reports. When relevant patient follow-up data are available, this should 
also be reported. Specifically, investigators reporting on research involving human 
subjects or animals must have prior approval from an institutional review board. This 
approval should be mentioned in the methods section of the manuscript. In countries 
where institutional review boards are not available; the authors must include a 
statement that research was conducted in accordance with the Helsinki Declaration as 
revised 1989. All studies involving animals must state that the authors followed the 
guidelines for the use and care of laboratory animals of the author's institution or the 
National Research Council or any national law pertaining to animal research care. 
Declaration of interest  
 
All authors must disclose any financial and personal relationships with other people or 
organizations that could inappropriately influence (bias) their work. Examples of 
potential competing interests include employment, consultancies, stock ownership, 
honoraria, paid expert testimony, patent applications/registrations, and grants or other 
funding. Authors must disclose any interests in two places: 1. A summary declaration 
of interest statement in the title page file (if double-blind) or the manuscript file (if 
single-blind). If there are no interests to declare then please state this: 'Declarations of 
interest: none'. This summary statement will be ultimately published if the article is 
accepted. 2. Detailed disclosures as part of a separate Declaration of Interest form, 
which forms part of the journal's official records. It is important for potential interests 
to be declared in both places and that the information matches. More information. 
Submission declaration  
 
Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract, a published lecture or academic thesis, 
see 'Multiple, redundant or concurrent publication' for more information), that it is not 
under consideration for publication elsewhere, that its publication is approved by all 
authors and tacitly or explicitly by the responsible authorities where the work was 
carried out, and that, if accepted, it will not be published elsewhere in the same form, 
in English or in any other language, including electronically without the written 
consent of the copyright-holder. 
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Preprints  
Please note that preprints can be shared anywhere at any time, in line with Elsevier's 
sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior 
publication (see 'Multiple, redundant or concurrent publication' for more information). 
Use of inclusive language  
 
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive 
to differences, and promotes equal opportunities. Content should make no 
assumptions about the beliefs or commitments of any reader; contain nothing which 
might imply that one individual is superior to another on the grounds of age, gender, 
race, ethnicity, culture, sexual orientation, disability or health condition; and use 
inclusive language throughout. Authors should ensure that writing is free from bias, 
stereotypes, slang, reference to dominant culture and/or cultural assumptions. We 
advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") 
as default/wherever possible to avoid using "he, she," or "he/she." We recommend 
avoiding the use of descriptors that refer to personal attributes such as age, gender, 
race, ethnicity, culture, sexual orientation, disability or health condition unless they 
are relevant and valid. These guidelines are meant as a point of reference to help 
identify appropriate language but are by no means exhaustive or definitive. 
Contributors  
 
Each author is required to declare his or her individual contribution to the article: all 
authors must have materially participated in the research and/or article preparation, so 
roles for all authors should be described. The statement that all authors have approved 
the final article should be true and included in the disclosure. 
Changes to authorship  
 
Authors are expected to consider carefully the list and order of authors before 
submitting their manuscript and provide the definitive list of authors at the time of the 
original submission. Any addition, deletion or rearrangement of author names in the 
authorship list should be made only before the manuscript has been accepted and only 
if approved by the journal Editor. To request such a change, the Editor must receive 
the following from the corresponding author: (a) the reason for the change in author 
list and (b) written confirmation (e-mail, letter) from all authors that they agree with 
the addition, removal or rearrangement. In the case of addition or removal of authors, 
this includes confirmation from the author being added or removed. 
Only in exceptional circumstances will the Editor consider the addition, deletion or 
rearrangement of authors after the manuscript has been accepted. While the Editor 
considers the request, publication of the manuscript will be suspended. If the 
manuscript has already been published in an online issue, any requests approved by 
the Editor will result in a corrigendum. 
Article transfer service  
This journal is part of our Article Transfer Service. This means that if the Editor feels 
your article is more suitable in one of our other participating journals, then you may 
be asked to consider transferring the article to one of those. If you agree, your article 
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will be transferred automatically on your behalf with no need to reformat. Please note 
that your article will be reviewed again by the new journal. More information. 
Copyright  
 
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing 
Agreement' (see more information on this). An e-mail will be sent to the 
corresponding author confirming receipt of the manuscript together with a 'Journal 
Publishing Agreement' form or a link to the online version of this agreement. 
Subscribers may reproduce tables of contents or prepare lists of articles including 
abstracts for internal circulation within their institutions. Permission of the Publisher 
is required for resale or distribution outside the institution and for all other derivative 
works, including compilations and translations. If excerpts from other copyrighted 
works are included, the author(s) must obtain written permission from the copyright 
owners and credit the source(s) in the article. Elsevier has preprinted forms for use by 
authors in these cases. 
For gold open access articles: Upon acceptance of an article, authors will be asked to 
complete an 'Exclusive License Agreement' (more information). Permitted third party 
reuse of gold open access articles is determined by the author's choice of user license. 
Author rights 
As an author you (or your employer or institution) have certain rights to reuse your 
work. More information. 
Elsevier supports responsible sharing  
Find out how you can share your research published in Elsevier journals. 
Role of the funding source  
 
You are requested to identify who provided financial support for the conduct of the 
research and/or preparation of the article and to briefly describe the role of the 
sponsor(s), if any, in study design; in the collection, analysis and interpretation of 
data; in the writing of the report; and in the decision to submit the article for 
publication. If the funding source(s) had no such involvement then this should be 
stated. 
Open access  
 
Please visit our Open Access page for more information. 
Elsevier Researcher Academy  
Researcher Academy is a free e-learning platform designed to support early and mid-
career researchers throughout their research journey. The "Learn" environment at 
Researcher Academy offers several interactive modules, webinars, downloadable 
guides and resources to guide you through the process of writing for research and 
going through peer review. Feel free to use these free resources to improve your 
submission and navigate the publication process with ease. 
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Language (usage and editing services)  
Please write your text in good English (American or British usage is accepted, but not 
a mixture of these). Authors who feel their English language manuscript may require 
editing to eliminate possible grammatical or spelling errors and to conform to correct 
scientific English may wish to use the English Language Editing service available 
from Elsevier's Author Services. 
Submission  
 
Our online submission system guides you stepwise through the process of entering 
your article details and uploading your files. The system converts your article files to 
a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) 
are required to typeset your article for final publication. All correspondence, including 
notification of the Editor's decision and requests for revision, is sent by e-mail. 
Manuscript Submission  
 
The Journal of Affective Disorders now proceeds totally online via an electronic 
submission system. Mail submissions will no longer be accepted. By accessing the 
online submission system, https://www.evise.com/profile/api/navigate/JAD, you will 
be guided stepwise through the creation and uploading of the various files. When 
submitting a manuscript online, authors need to provide an electronic version of their 
manuscript and any accompanying figures and tables.  
The author should select from a list of scientific classifications, which will be used to 
help the editors select reviewers with appropriate expertise, and an article type for 
their manuscript. Once the uploading is done, the system automatically generates an 
electronic (PDF) proof, which is then used for reviewing. All correspondence, 
including the Editor's decision and request for revisions, will be processed through the 
system and will reach the corresponding author by e-mail.  
Once a manuscript has successfully been submitted via the online submission system 
authors may track the status of their manuscript using the online submission system 
(details will be provided by e-mail). If your manuscript is accepted by the journal, 
subsequent tracking facilities are available on Elsevier's Author Gateway, using the 
unique reference number provided by Elsevier and corresponding author name 
(details will be provided by e-mail).  
Authors may send queries concerning the submission process or journal procedures to 
our Editors-in-Chief 
Paolo Brambilla: paolo.brambilla1@unimi.it or Jair Soares: 
Jair.C.Soares@uth.tmc.edu.  
Please submit your article via https://www.evise.com/profile/api/navigate/JAD. 
Types of Papers  
The Journal primarily publishes:  
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Full-Length Research Papers (up to 5000 words, excluding references and up to 6 
tables/figures) 
Review Articles and Meta-analyses (up to 8000 words, excluding references and up to 
10 tables/figures) 
Short Communications (up to 2000 words, 20 references, 2 tables/figures) 
Correspondence (up to 1000 words, 10 references, 1 table/figure). 
At the discretion of the accepting Editor-in-Chief, and/or based on reviewer feedback, 
authors may be allowed fewer or more than these guidelines. 
Retraction Policy  
It is a general principle of scholarly communication that the editor of a learned journal 
is solely and independently responsible for deciding which articles submitted to the 
journal shall be published. In making this decision the editor is guided by policies of 
the journal's editorial board and constrained by such legal requirements in force 
regarding libel, copyright infringement and plagiarism. Although electronic methods 
are available to detect plagiarism and duplicate publications, editors nonetheless rely 
in large part on the integrity of authors to fulfil their responsibilities within the 
requirements of publication ethics and only submit work to which the can rightfully 
claim authorship and which has not previously been published.  
An outcome of this principle is the importance of the scholarly archive as a 
permanent, historic record of the transactions of scholarship. Articles that have been 
published shall remain extant, exact and unaltered as far as is possible. However, very 
occasionally circumstances may arise where an article is published that must later be 
retracted or even removed. Such actions must not be undertaken lightly and can only 
occur under exceptional circumstances, such as:  
• Article Withdrawal: Only used for Articles in Press which represent early versions 
of articles and sometimes contain errors, or may have been accidentally submitted 
twice. Occasionally, but less frequently, the articles may represent infringements of 
professional ethical codes, such as multiple submission, bogus claims of authorship, 
plagiarism, fraudulent use of data or the like. • Article Retraction: Infringements of 
professional ethical codes, such as multiple submission, bogus claims of authorship, 
plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to 
correct errors in submission or publication. • Article Removal: Legal limitations upon 
the publisher, copyright holder or author(s). • Article Replacement: Identification of 
false or inaccurate data that, if acted upon, would pose a serious health risk. For the 
full policy and further details, please refer 
https://www.elsevier.com/about/publishing-guidelines/policies/article-withdrawal 
Referees  
Please submit the names and institutional e-mail addresses of several potential 
referees. For more details, visit our Support site. Note that the editor retains the sole 
right to decide whether or not the suggested reviewers are used. 
Preparation of Manuscripts  
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Articles should be in English. The title page should appear as a separate sheet bearing 
title (without article type), author names and affiliations, and a footnote with the 
corresponding author's full contact information, including address, telephone and fax 
numbers, and e-mail address (failure to include an e-mail address can delay 
processing of the manuscript).  
Papers should be divided into sections headed by a caption (e.g., Introduction, 
Methods, Results, Discussion). A structured abstract of no more than 250 words 
should appear on a separate page with the following headings and order: Background, 
Methods, Results, Limitations, Conclusions (which should contain a statement about 
the clinical relevance of the research). A list of three to six key words should appear 
under the abstract. Authors should note that the 'limitations' section both in the 
discussion of the paper AND IN A STRUCTURED ABSTRACT are essential. 
Failure to include it may delay in processing the paper, decision making and final 
publication.  
Figures and Photographs 
Figures and Photographs of good quality should be submitted online as a separate file. 
Please use a lettering that remains clearly readable even after reduction to about 66%. 
For every figure or photograph, a legend should be provided. All authors wishing to 
use illustrations already published must first obtain the permission of the author and 
publisher and/or copyright holders and give precise reference to the original work. 
This permission must include the right to publish in electronic media.  
Tables 
Tables should be numbered consecutively with Arabic numerals and must be cited in 
the text in sequence. Each table, with an appropriate brief legend, comprehensible 
without reference to the text, should be typed on a separate page and uploaded online. 
Tables should be kept as simple as possible and wherever possible a graphical 
representation used instead. Table titles should be complete but brief. Information 
other than that defining the data should be presented as footnotes.  
Please refer to the generic Elsevier artwork instructions: 
http://authors.elsevier.com/artwork/jad. 
 
Preparation of supplementary data 
Elsevier accepts electronic supplementary material to support and enhance your 
scientific research. Supplementary files offer the author additional possibilities to 
publish supporting applications, movies, animation sequences, high-resolution 
images, background datasets, sound clips and more. 
Supplementary files supplied will be published online alongside the electronic version 
of your article in Elsevier web products, including ScienceDirect: 
http://www.sciencedirect.com. In order to ensure that your submitted material is 
directly usable, please ensure that data is provided in one of our recommended file 
formats. Authors should submit the material in electronic format together with the 
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article and supply a concise and descriptive caption for each file. For more detailed 
instructions please visit our Author Gateway at: https://www.elsevier.com/authors. 
Colour reproduction 
The Journal of Affective Disorders is now also included in a new initiative from 
Elsevier: 'Colourful e-Products'. Through this initiative, figures that appear in black & 
white in print can appear in colour, online, in ScienceDirect at 
http://www.sciencedirect.com. 
There is no extra charge for authors who participate.  
For colour reproduction in print, you will receive information regarding the costs 
from Elsevier after receipt of your accepted article. Please indicate your preference 
for colour in print or on the Web only. Because of technical complications which can 
arise by converting colour figures to "grey scale" (for the printed version should you 
not opt for colour in print) please submit in addition usable black and white versions 
of all the colour illustrations. For further information on the preparation of electronic 
artwork, please see http://authors.elsevier.com/artwork/jad. 
Peer review  
 
This journal operates a single blind review process. All contributions will be initially 
assessed by the editor for suitability for the journal. Papers deemed suitable are then 
typically sent to a minimum of two independent expert reviewers to assess the 
scientific quality of the paper. The Editor is responsible for the final decision 
regarding acceptance or rejection of articles. The Editor's decision is final. More 
information on types of peer review. 
Use of word processing software  
It is important that the file be saved in the native format of the word processor used. 
The text should be in single-column format. Keep the layout of the text as simple as 
possible. Most formatting codes will be removed and replaced on processing the 
article. In particular, do not use the word processor's options to justify text or to 
hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. 
When preparing tables, if you are using a table grid, use only one grid for each 
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to 
align columns. The electronic text should be prepared in a way very similar to that of 
conventional manuscripts (see also the Guide to Publishing with Elsevier). Note that 
source files of figures, tables and text graphics will be required whether or not you 
embed your figures in the text. See also the section on Electronic artwork.  
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 
'grammar-check' functions of your word processor. 
Highlights  
 
Highlights are mandatory for this journal as they help increase the discoverability of 
your article via search engines. They consist of a short collection of bullet points that 
capture the novel results of your research as well as new methods that were used 
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during the study (if any). Please have a look at the examples here: example 
Highlights.  
Highlights should be submitted in a separate editable file in the online submission 
system. Please use 'Highlights' in the file name and include 3 to 5 bullet points 
(maximum 85 characters, including spaces, per bullet point). 
Abstract  
 
A concise and factual abstract is required. The abstract should state briefly the 
purpose of the research, the principal results and major conclusions. An abstract is 
often presented separately from the article, so it must be able to stand alone. For this 
reason, References should be avoided, but if essential, then cite the author(s) and 
year(s). Also, non-standard or uncommon abbreviations should be avoided, but if 
essential they must be defined at their first mention in the abstract itself. 
Graphical abstract  
Although a graphical abstract is optional, its use is encouraged as it draws more 
attention to the online article. The graphical abstract should summarize the contents of 
the article in a concise, pictorial form designed to capture the attention of a wide 
readership. Graphical abstracts should be submitted as a separate file in the online 
submission system. Image size: Please provide an image with a minimum of 531 × 
1328 pixels (h × w) or proportionally more. The image should be readable at a size of 
5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, 
PDF or MS Office files. You can view Example Graphical Abstracts on our 
information site. 
Authors can make use of Elsevier's Illustration Services to ensure the best 
presentation of their images and in accordance with all technical requirements. 
Keywords  
 
Immediately after the abstract, provide a maximum of 6 keywords, using American 
spelling and avoiding general and plural terms and multiple concepts (avoid, for 
example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly 
established in the field may be eligible. These keywords will be used for indexing 
purposes. 
Abbreviations  
Define abbreviations that are not standard in this field in a footnote to be placed on 
the first page of the article. Such abbreviations that are unavoidable in the abstract 
must be defined at their first mention there, as well as in the footnote. Ensure 
consistency of abbreviations throughout the article. 
Acknowledgements  
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the 
title or otherwise. List here those individuals who provided help during the research 
(e.g., providing language help, writing assistance or proof reading the article, etc.). 
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Formatting of funding sources  
List funding sources in this standard way to facilitate compliance to funder's 
requirements: 
Funding: This work was supported by the National Institutes of Health [grant numbers 
xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; 
and the United States Institutes of Peace [grant number aaaa]. 
It is not necessary to include detailed descriptions on the program or type of grants 
and awards. When funding is from a block grant or other resources available to a 
university, college, or other research institution, submit the name of the institute or 
organization that provided the funding. 
If no funding has been provided for the research, please include the following 
sentence: 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
Nomenclature and units  
Follow internationally accepted rules and conventions: use the international system of 
units (SI). If other quantities are mentioned, give their equivalent in SI. You are urged 
to consult IUPAC: Nomenclature of Organic Chemistry for further information. 
Math formulae  
Please submit math equations as editable text and not as images. Present simple 
formulae in line with normal text where possible and use the solidus (/) instead of a 
horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be 
presented in italics. Powers of e are often more conveniently denoted by exp. Number 
consecutively any equations that have to be displayed separately from the text (if 
referred to explicitly in the text). 
Footnotes  
Footnotes should be used sparingly. Number them consecutively throughout the 
article. Many word processors can build footnotes into the text, and this feature may 
be used. Otherwise, please indicate the position of footnotes in the text and list the 
footnotes themselves separately at the end of the article. Do not include footnotes in 
the Reference list. 
Artwork  
Electronic artwork  
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Embed the used fonts if the application provides that option.  
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New 
Roman, Symbol, or use fonts that look similar.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
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• Size the illustrations close to the desired dimensions of the published version.  
• Submit each illustration as a separate file. 
• Ensure that color images are accessible to all, including those with impaired color 
vision. 
A detailed guide on electronic artwork is available. 
You are urged to visit this site; some excerpts from the detailed information are given 
here. 
Formats 
If your electronic artwork is created in a Microsoft Office application (Word, 
PowerPoint, Excel) then please supply 'as is' in the native document format.  
Regardless of the application used other than Microsoft Office, when your electronic 
artwork is finalized, please 'Save as' or convert the images to one of the following 
formats (note the resolution requirements for line drawings, halftones, and 
line/halftone combinations given below):  
EPS (or PDF): Vector drawings, embed all used fonts.  
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 
300 dpi.  
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a 
minimum of 1000 dpi.  
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to 
a minimum of 500 dpi. 
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these 
typically have a low number of pixels and limited set of colors;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content. 
Color artwork  
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS 
(or PDF), or MS Office files) and with the correct resolution. If, together with your 
accepted article, you submit usable color figures then Elsevier will ensure, at no 
additional charge, that these figures will appear in color online (e.g., ScienceDirect 
and other sites) regardless of whether or not these illustrations are reproduced in color 
in the printed version. For color reproduction in print, you will receive information 
regarding the costs from Elsevier after receipt of your accepted article. Please indicate 
your preference for color: in print or online only. Further information on the 
preparation of electronic artwork. 
Illustration services  
Elsevier's Author Services offers Illustration Services to authors preparing to submit a 
manuscript but concerned about the quality of the images accompanying their article. 
Elsevier's expert illustrators can produce scientific, technical and medical-style 
images, as well as a full range of charts, tables and graphs. Image 'polishing' is also 
available, where our illustrators take your image(s) and improve them to a 
professional standard. Please visit the website to find out more. 
Tables  
 
Please submit tables as editable text and not as images. Tables can be placed either 
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next to the relevant text in the article, or on separate page(s) at the end. Number tables 
consecutively in accordance with their appearance in the text and place any table 
notes below the table body. Be sparing in the use of tables and ensure that the data 
presented in them do not duplicate results described elsewhere in the article. Please 
avoid using vertical rules and shading in table cells. 
References  
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list 
(and vice versa). Any references cited in the abstract must be given in full. 
Unpublished results and personal communications are not recommended in the 
reference list, but may be mentioned in the text. If these references are included in the 
reference list they should follow the standard reference style of the journal and should 
include a substitution of the publication date with either 'Unpublished results' or 
'Personal communication'. Citation of a reference as 'in press' implies that the item has 
been accepted for publication. 
Data references  
This journal encourages you to cite underlying or relevant datasets in your manuscript 
by citing them in your text and including a data reference in your Reference List. Data 
references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add 
[dataset] immediately before the reference so we can properly identify it as a data 
reference. The [dataset] identifier will not appear in your published article. 
Reference management software  
Most Elsevier journals have their reference template available in many of the most 
popular reference management software products. These include all products that 
support Citation Style Language styles, such as Mendeley. Using citation plug-ins 
from these products, authors only need to select the appropriate journal template when 
preparing their article, after which citations and bibliographies will be automatically 
formatted in the journal's style. If no template is yet available for this journal, please 
follow the format of the sample references and citations as shown in this Guide. If you 
use reference management software, please ensure that you remove all field codes 
before submitting the electronic manuscript. More information on how to remove 
field codes from different reference management software. 
 
Users of Mendeley Desktop can easily install the reference style for this journal by 
clicking the following link: 
http://open.mendeley.com/use-citation-style/journal-of-affective-disorders 
When preparing your manuscript, you will then be able to select this style using the 
Mendeley plug-ins for Microsoft Word or LibreOffice. 
Reference style  
Text: All citations in the text should refer to:  
1. Single author: the author's name (without initials, unless there is ambiguity) and the 
year of publication;  
2. Two authors: both authors' names and the year of publication;  
3. Three or more authors: first author's name followed by 'et al.' and the year of 
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publication.  
Citations may be made directly (or parenthetically). Groups of references can be listed 
either first alphabetically, then chronologically, or vice versa.  
Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999)…. 
Or, as demonstrated (Jones, 1999; Allan, 2000)… Kramer et al. (2010) have recently 
shown …'  
List: References should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) in the 
same year must be identified by the letters 'a', 'b', 'c', etc., placed after the year of 
publication.  
Examples:  
Reference to a journal publication:  
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a scientific 
article. J. Sci. Commun. 163, 51–59. https://doi.org/10.1016/j.Sc.2010.00372.  
Reference to a journal publication with an article number:  
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2018. The art of writing a scientific 
article. Heliyon. 19, e00205. https://doi.org/10.1016/j.heliyon.2018.e00205.  
Reference to a book:  
Strunk Jr., W., White, E.B., 2000. The Elements of Style, fourth ed. Longman, New 
York.  
Reference to a chapter in an edited book:  
Mettam, G.R., Adams, L.B., 2009. How to prepare an electronic version of your 
article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-
Publishing Inc., New York, pp. 281–304. 
Reference to a website: 
Cancer Research UK, 1975. Cancer statistics reports for the UK. 
http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/ (accessed 
13 March 2003). 
Reference to a dataset: 
[dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T., 2015. Mortality data for 




Elsevier accepts video material and animation sequences to support and enhance your 
scientific research. Authors who have video or animation files that they wish to 
submit with their article are strongly encouraged to include links to these within the 
body of the article. This can be done in the same way as a figure or table by referring 
to the video or animation content and noting in the body text where it should be 
placed. All submitted files should be properly labeled so that they directly relate to the 
video file's content. In order to ensure that your video or animation material is directly 
usable, please provide the file in one of our recommended file formats with a 
preferred maximum size of 150 MB per file, 1 GB in total. Video and animation files 
supplied will be published online in the electronic version of your article in Elsevier 
Web products, including ScienceDirect. Please supply 'stills' with your files: you can 
choose any frame from the video or animation or make a separate image. These will 
be used instead of standard icons and will personalize the link to your video data. For 
more detailed instructions please visit our video instruction pages. Note: since video 
and animation cannot be embedded in the print version of the journal, please provide 
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text for both the electronic and the print version for the portions of the article that 
refer to this content. 
Data visualization  
 
Include interactive data visualizations in your publication and let your readers interact 
and engage more closely with your research. Follow the instructions here to find out 
about available data visualization options and how to include them with your article. 
Supplementary material  
 
Supplementary material such as applications, images and sound clips, can be 
published with your article to enhance it. Submitted supplementary items are 
published exactly as they are received (Excel or PowerPoint files will appear as such 
online). Please submit your material together with the article and supply a concise, 
descriptive caption for each supplementary file. If you wish to make changes to 
supplementary material during any stage of the process, please make sure to provide 
an updated file. Do not annotate any corrections on a previous version. Please switch 
off the 'Track Changes' option in Microsoft Office files as these will appear in the 
published version. 
Research data  
 
This journal encourages and enables you to share data that supports your research 
publication where appropriate, and enables you to interlink the data with your 
published articles. Research data refers to the results of observations or 
experimentation that validate research findings. To facilitate reproducibility and data 
reuse, this journal also encourages you to share your software, code, models, 
algorithms, protocols, methods and other useful materials related to the project. 
Below are a number of ways in which you can associate data with your article or 
make a statement about the availability of your data when submitting your 
manuscript. If you are sharing data in one of these ways, you are encouraged to cite 
the data in your manuscript and reference list. Please refer to the "References" section 
for more information about data citation. For more information on depositing, sharing 
and using research data and other relevant research materials, visit the research data 
page. 
 
 
